Bristol-Myers Squibb Company (BMY) NYSE
$48.24 (0.35) (-0.72%)
Market Cap: $97.80B
As of 09/12/24 04:00 PM EDT. Market closed.
Bristol-Myers Squibb Company (BMY)
NYSE
$48.24
(0.35) (-0.72%)
Market Cap: $97.80B
As of 09/12/24 04:00 PM EDT. Market closed.
Add to Portfolio
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dr. Christopher S. Boerner Ph.D.
Full Time Employees
34,100
CEO Compensation (Base)
$1.70M
CEO Compensation (Total)
$19.78M
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Dr. Christopher S. Boerner Ph.D.
Full Time Employees
34,100
CEO Compensation (Base)
$1.70M
CEO Compensation (Total)
$19.78M
URL
Address
430 East 29th Street, NY, New York, 10016.
PRICE CHART FOR BRISTOL-MYERS SQUIBB COMPANY
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$48.38
Previous Close
$48.59
Days Range
$47.76 - $48.57
52 week range
$39.35 - $60.55
Volume
4,159,848
Avg. Volume (30 days)
14,794,680
Market Cap
$97.80B
Dividend Yield
4.91%
P/E
(14.84)
Shares Outstanding
2,027,400,000
Open
$48.38
Previous Close
$48.59
Days Range
$47.76 - $48.57
52 week range
$39.35 - $60.55
Volume
4,159,848
Avg. Volume (30 days)
14,794,680
Market Cap
$97.80B
Dividend Yield
4.91%
P/E
(14.84)
Shares Outstanding
2,027,400,000
FINANCIAL STATEMENTS FOR BRISTOL-MYERS SQUIBB COMPANY
LOADING...
INSIDER TRANSACTIONS FOR BRISTOL-MYERS SQUIBB COMPANY
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Gallman Cari | EVP, Corporate Affairs | Aug 01, 2024 | Option Exercise | $48.17 | 384 | 18,497 | 2,109 | Aug 05, 2024, 06:01 PM |
Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Apr 01, 2024 | Option Exercise | $52.99 | 1,196 | 63,376 | 5,336 | Apr 02, 2024, 06:45 PM |
Lenkowsky Adam | EVP, Chief Commercial Officer | Mar 10, 2024 | Option Exercise | $53.79 | 4,323 | 232,534 | 6,650 | Mar 12, 2024, 09:54 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2024 | Option Exercise | $53.79 | 16,660 | 896,141 | 347,385 | Mar 12, 2024, 09:43 PM |
Plenge Robert M | EVP, Chief Research Officer | Mar 10, 2024 | Option Exercise | $53.79 | 1,965 | 105,697 | 11,315 | Mar 12, 2024, 09:21 PM |
Poole Ahn Amanda | EVP, Chief Human Resources | Mar 10, 2024 | Option Exercise | $53.79 | 1,375 | 73,961 | 2,424 | Mar 12, 2024, 09:11 PM |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2024 | Option Exercise | $53.79 | 13,649 | 734,180 | 60,279 | Mar 12, 2024, 08:40 PM |
Holzer Phil M | SVP and Controller | Mar 10, 2024 | Option Exercise | $53.79 | 1,389 | 74,714 | 12,460 | Mar 12, 2024, 08:31 PM |
Hoch Lynelle | President, Cell Therapy Org. | Mar 10, 2024 | Option Exercise | $53.79 | 1,308 | 70,357 | 1,726 | Mar 12, 2024, 08:01 PM |
Gallman Cari | EVP, Corporate Affairs | Mar 10, 2024 | Option Exercise | $53.79 | 696 | 37,438 | 1,432 | Mar 12, 2024, 08:00 PM |
BOERNER CHRISTOPHER S. | Chief Executive Officer | Mar 10, 2024 | Option Exercise | $53.79 | 19,407 | 1,043,903 | 101,205 | Mar 12, 2024, 07:58 PM |
Elkins David V | EVP, Chief Financial Officer | Mar 10, 2024 | Option Exercise | $53.79 | 18,522 | 996,298 | 194,968 | Mar 12, 2024, 05:43 PM |
Caforio Giovanni | Executive Chair of the Board | Mar 10, 2024 | Option Exercise | $53.79 | 67,823 | 3,648,199 | 432,266 | Mar 12, 2024, 05:42 PM |
Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Feb 01, 2024 | Option Exercise | $48.67 | 754 | 36,697 | 5,286 | Feb 05, 2024, 07:10 PM |
BOERNER CHRISTOPHER S. | Chief Executive Officer | Dec 05, 2023 | Buy | $49.78 | 2,000 | 99,560 | 82,672 | Dec 07, 2023, 06:06 PM |
Plenge Robert M | EVP, Chief Research Officer | Dec 02, 2023 | Option Exercise | $50.10 | 274 | 13,727 | 6,926 | Dec 05, 2023, 06:23 PM |
Elkins David V | EVP, Chief Financial Officer | Dec 02, 2023 | Option Exercise | $50.10 | 3,730 | 186,873 | 168,612 | Dec 05, 2023, 06:22 PM |
BOERNER CHRISTOPHER S. | Chief Executive Officer | Dec 02, 2023 | Option Exercise | $50.10 | 1,350 | 67,635 | 80,672 | Dec 05, 2023, 06:21 PM |
BOERNER CHRISTOPHER S. | Chief Executive Officer | Nov 28, 2023 | Buy | $48.86 | 3,071 | 150,049 | 79,384 | Nov 30, 2023, 06:32 PM |
LEUNG SANDRA | EVP, General Counsel | Nov 21, 2023 | Option Exercise | $48.74 | 9,830 | 479,163 | 93,436 | Nov 24, 2023, 02:38 PM |
LEUNG SANDRA | EVP, General Counsel | Nov 21, 2023 | Option Exercise | $48.74 | 9,830 | 479,163 | 331,414 | Nov 24, 2023, 02:38 PM |
Samuels Theodore R. II | Director | Nov 20, 2023 | Buy | $49.81 | 8,500 | 423,385 | 35,500 | Nov 21, 2023, 07:01 PM |
Powell Ann | EVP, Chief Human Resources | Aug 24, 2023 | Sale | $61.25 | 17,986 | 1,101,643 | 27,868 | Aug 28, 2023, 05:28 PM |
Plenge Robert M | EVP, Chief Research Officer | Aug 03, 2023 | Sale | $61.14 | 732 | 44,754 | 6,584 | Aug 07, 2023, 05:24 PM |
Weese Michelle | EVP, Corporate Affairs | Jul 01, 2023 | Option Exercise | $63.95 | 682 | 43,614 | 3,453 | Jul 05, 2023, 05:26 PM |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Jul 01, 2023 | Option Exercise | $63.95 | 4,787 | 306,129 | 47,245 | Jul 05, 2023, 05:23 PM |
Lenkowsky Adam | EVP, Chief Commercial Officer | Jun 03, 2023 | Option Exercise | $65.66 | 551 | 36,179 | 526 | Jun 06, 2023, 07:39 PM |
VESSEY RUPERT | EVP & President, Research | May 03, 2023 | Sale | $67.06 | 50,385 | 3,378,818 | 47,751 | May 04, 2023, 05:51 PM |
Greenlees Sharon | SVP & Controller | May 02, 2023 | Option Exercise | $68.10 | 346 | 23,563 | 609 | May 03, 2023, 07:36 PM |
Mily Elizabeth | EVP, Strategy & BD | Apr 01, 2023 | Option Exercise | $69.31 | 3,198 | 221,653 | 34,734 | Apr 04, 2023, 08:40 PM |
Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Apr 01, 2023 | Option Exercise | $69.31 | 1,692 | 117,273 | 3,226 | Apr 04, 2023, 08:40 PM |
Mily Elizabeth | EVP, Strategy & BD | Mar 10, 2023 | Option Exercise | $65.71 | 14,040 | 922,568 | 30,396 | Mar 14, 2023, 08:40 PM |
VESSEY RUPERT | EVP & President, Research | Mar 10, 2023 | Option Exercise | $65.71 | 38,498 | 2,529,704 | 98,136 | Mar 14, 2023, 08:34 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2023 | Option Exercise | $65.71 | 34,104 | 2,240,974 | 341,244 | Mar 14, 2023, 08:28 PM |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2023 | Option Exercise | $65.71 | 22,395 | 1,471,575 | 42,675 | Mar 14, 2023, 08:18 PM |
Powell Ann | EVP, Chief Human Resources | Mar 10, 2023 | Option Exercise | $65.71 | 16,810 | 1,104,585 | 45,854 | Mar 14, 2023, 08:18 PM |
Weese Michelle | EVP, Corporate Affairs | Mar 10, 2023 | Option Exercise | $65.71 | 594 | 39,032 | 2,250 | Mar 14, 2023, 08:14 PM |
Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Mar 10, 2023 | Option Exercise | $65.71 | 1,243 | 81,678 | 3,497 | Mar 14, 2023, 08:14 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Mar 10, 2023 | Option Exercise | $65.71 | 34,620 | 2,274,880 | 76,313 | Mar 14, 2023, 08:13 PM |
Elkins David V | EVP, Chief Financial Officer | Mar 10, 2023 | Option Exercise | $65.71 | 41,331 | 2,715,860 | 163,550 | Mar 14, 2023, 08:13 PM |
Caforio Giovanni | Board Chair and CEO | Mar 10, 2023 | Option Exercise | $65.71 | 137,989 | 9,067,257 | 367,935 | Mar 14, 2023, 08:13 PM |
Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | Mar 10, 2023 | Option Exercise | $65.71 | 914 | 60,059 | 1,612 | Mar 14, 2023, 08:12 PM |
Caforio Giovanni | Board Chair and CEO | Feb 06, 2023 | Sale | $74.65 | 240,000 | 17,916,000 | 236,104 | Feb 08, 2023, 08:09 PM |
Powell Ann | EVP, Chief Human Resources | Feb 06, 2023 | Sale | $74.69 | 11,183 | 835,258 | 23,043 | Feb 08, 2023, 08:09 PM |
Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | Feb 01, 2023 | Option Exercise | $71.23 | 731 | 52,069 | 1,812 | Feb 03, 2023, 07:18 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Dec 02, 2022 | Option Exercise | $81.13 | 1,349 | 109,444 | 43,254 | Dec 06, 2022, 07:32 PM |
Elkins David V | EVP, Chief Financial Officer | Dec 02, 2022 | Option Exercise | $81.13 | 4,498 | 364,923 | 124,080 | Dec 06, 2022, 06:44 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Dec 02, 2022 | Option Exercise | $81.13 | 4,498 | 364,923 | 61,373 | Dec 06, 2022, 06:43 PM |
Powell Ann | EVP, Chief Human Resources | Nov 09, 2022 | Sale | $80.45 | 16,250 | 1,307,312 | 34,226 | Nov 14, 2022, 06:57 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Nov 07, 2022 | Option Exercise | $58.31 | 52,604 | 3,067,529 | 102,989 | Nov 09, 2022, 08:38 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Nov 07, 2022 | Sale | $78.88 | 45,910 | 3,621,381 | 57,079 | Nov 09, 2022, 08:38 PM |
Caforio Giovanni | Board Chair and CEO | Sep 20, 2022 | Sale | $69.71 | 25,000 | 1,742,750 | 476,104 | Sep 22, 2022, 05:12 PM |
Caforio Giovanni | Board Chair and CEO | Sep 15, 2022 | Sale | $71.84 | 50,000 | 3,592,000 | 501,104 | Sep 16, 2022, 05:12 PM |
Elkins David V | EVP, Chief Financial Officer | Sep 13, 2022 | Option Exercise | $48.49 | 123,277 | 5,977,702 | 223,737 | Sep 15, 2022, 07:29 PM |
Elkins David V | EVP, Chief Financial Officer | Sep 13, 2022 | Sale | $71.30 | 133,951 | 9,551,167 | 119,786 | Sep 15, 2022, 07:29 PM |
Powell Ann | EVP, Chief Human Resources | Sep 14, 2022 | Sale | $70.75 | 25,000 | 1,768,750 | 50,476 | Sep 15, 2022, 07:29 PM |
Caforio Giovanni | Board Chair and CEO | Jun 13, 2022 | Sale | $74.04 | 30,000 | 2,221,200 | 551,104 | Jun 14, 2022, 05:58 PM |
LEUNG SANDRA | EVP, General Counsel | Jun 06, 2022 | Sale | $74.89 | 65,000 | 4,867,850 | 308,627 | Jun 07, 2022, 05:49 PM |
Mily Elizabeth | EVP, Strategy & BD | Apr 01, 2022 | Option Exercise | $73.82 | 3,333 | 246,042 | 11,342 | Apr 04, 2022, 06:13 PM |
Caforio Giovanni | Board Chair and CEO | Mar 21, 2022 | Sale | $71.52 | 25,000 | 1,788,000 | 581,524 | Mar 23, 2022, 07:43 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Mar 16, 2022 | Option Exercise | $57.00 | 47,305 | 2,696,612 | 93,613 | Mar 18, 2022, 05:50 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Mar 16, 2022 | Sale | $69.25 | 74,559 | 5,162,973 | 50,385 | Mar 18, 2022, 05:50 PM |
Santiago Karen Murphy | SVP & Controller | Mar 14, 2022 | Sale | $69.19 | 6,577 | 455,096 | 16,704 | Mar 16, 2022, 07:32 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Mar 14, 2022 | Sale | $69.20 | 29,532 | 2,043,526 | 41,966 | Mar 16, 2022, 07:32 PM |
Caforio Giovanni | Board Chair and CEO | Mar 10, 2022 | Option Exercise | $68.42 | 158,890 | 10,871,254 | 606,524 | Mar 14, 2022, 09:20 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2022 | Option Exercise | $68.42 | 44,901 | 3,072,126 | 373,627 | Mar 14, 2022, 09:20 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Mar 10, 2022 | Option Exercise | $68.42 | 34,545 | 2,363,569 | 71,498 | Mar 14, 2022, 09:19 PM |
Elkins David V | EVP, Chief Financial Officer | Mar 10, 2022 | Option Exercise | $68.42 | 9,222 | 630,969 | 130,460 | Mar 14, 2022, 09:18 PM |
Powell Ann | EVP, Chief Human Resources | Mar 10, 2022 | Option Exercise | $68.42 | 20,369 | 1,393,647 | 75,476 | Mar 14, 2022, 09:17 PM |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2022 | Option Exercise | $68.42 | 5,205 | 356,126 | 16,722 | Mar 14, 2022, 09:17 PM |
Santiago Karen Murphy | SVP & Controller | Mar 10, 2022 | Option Exercise | $68.42 | 6,223 | 425,778 | 23,281 | Mar 14, 2022, 09:16 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Mar 10, 2022 | Option Exercise | $68.42 | 8,751 | 598,743 | 77,639 | Mar 14, 2022, 09:16 PM |
Mily Elizabeth | EVP, Strategy & BD | Mar 10, 2022 | Option Exercise | $68.42 | 1,875 | 128,287 | 6,820 | Mar 14, 2022, 09:16 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Mar 01, 2022 | Option Exercise | $68.63 | 10,303 | 707,095 | 69,284 | Mar 03, 2022, 05:33 PM |
Elkins David V | EVP, Chief Financial Officer | Mar 01, 2022 | Option Exercise | $68.63 | 10,381 | 712,448 | 121,653 | Mar 03, 2022, 05:33 PM |
Caforio Giovanni | Board Chair and CEO | Feb 24, 2022 | Sale | $67.00 | 30,000 | 2,010,000 | 453,455 | Feb 28, 2022, 04:44 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Feb 04, 2022 | Option Exercise | $64.99 | 1,312 | 85,267 | 56,237 | Feb 08, 2022, 06:10 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Dec 16, 2021 | Sale | $61.99 | 19,298 | 1,196,252 | 45,060 | Dec 17, 2021, 05:08 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Dec 02, 2021 | Option Exercise | $55.41 | 4,498 | 249,234 | 51,258 | Dec 06, 2021, 06:27 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Dec 02, 2021 | Option Exercise | $55.41 | 1,350 | 74,803 | 38,512 | Dec 06, 2021, 06:27 PM |
Elkins David V | EVP, Chief Financial Officer | Dec 02, 2021 | Option Exercise | $55.41 | 4,498 | 249,234 | 84,302 | Dec 06, 2021, 06:27 PM |
von Autenried Paul | EVP, Chief Information Officer | Nov 22, 2021 | Sale | $57.17 | 18,363 | 1,049,813 | 96,307 | Nov 24, 2021, 05:25 PM |
von Autenried Paul | EVP, Chief Information Officer | Nov 24, 2021 | Sale | $56.92 | 17,353 | 987,733 | 63,536 | Nov 24, 2021, 05:25 PM |
von Autenried Paul | EVP, Chief Information Officer | Nov 23, 2021 | Sale | $57.47 | 15,418 | 886,072 | 80,889 | Nov 24, 2021, 05:25 PM |
Caforio Giovanni | Board Chair and CEO | Sep 20, 2021 | Sale | $60.64 | 25,000 | 1,516,000 | 483,980 | Sep 22, 2021, 05:19 PM |
Elkins David V | EVP, Chief Financial Officer | Aug 12, 2021 | Option Exercise | $48.49 | 70,000 | 3,394,300 | 139,699 | Aug 16, 2021, 05:51 PM |
Elkins David V | EVP, Chief Financial Officer | Aug 12, 2021 | Sale | $66.95 | 99,691 | 6,674,497 | 80,008 | Aug 16, 2021, 05:51 PM |
Caforio Giovanni | Chairman and CEO | Aug 02, 2021 | Sale | $68.58 | 20,000 | 1,371,600 | 508,980 | Aug 04, 2021, 04:47 PM |
Powell Ann | EVP, Chief Human Resources | Aug 03, 2021 | Sale | $68.57 | 23,280 | 1,596,310 | 47,613 | Aug 04, 2021, 04:46 PM |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | Jul 30, 2021 | Sale | $67.90 | 2,466 | 167,441 | 13,777 | Aug 03, 2021, 04:56 PM |
Elkins David V | EVP, Chief Financial Officer | Aug 01, 2021 | Option Exercise | $67.87 | 23,736 | 1,610,962 | 109,699 | Aug 03, 2021, 04:55 PM |
LEUNG SANDRA | EVP, General Counsel | Jul 30, 2021 | Sale | $68.04 | 29,390 | 1,999,696 | 339,967 | Aug 03, 2021, 04:54 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Jul 30, 2021 | Option Exercise | $58.49 | 150,967 | 8,830,108 | 187,617 | Aug 03, 2021, 04:50 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Jul 30, 2021 | Sale | $68.07 | 158,393 | 10,782,154 | 46,964 | Aug 03, 2021, 04:50 PM |
von Autenried Paul | EVP, Chief Information Officer | Jul 30, 2021 | Sale | $68.06 | 25,000 | 1,701,375 | 114,670 | Aug 03, 2021, 04:49 PM |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Jul 01, 2021 | Option Exercise | $66.56 | 4,786 | 318,556 | 11,752 | Jul 06, 2021, 04:38 PM |
Santiago Karen Murphy | SVP & Controller | Jul 01, 2021 | Option Exercise | $66.56 | 547 | 36,408 | 14,498 | Jul 06, 2021, 04:38 PM |
Eid Joseph | SVP,Head Glob. Medical Affairs | Jun 03, 2021 | Option Exercise | $64.80 | 738 | 47,822 | 9,485 | Jun 04, 2021, 04:36 PM |
Mily Elizabeth | EVP, Strategy & BD | Apr 01, 2021 | Option Exercise | $62.93 | 2,952 | 185,769 | 4,241 | Apr 02, 2021, 01:14 PM |
Caforio Giovanni | Chairman and CEO | Mar 22, 2021 | Sale | $62.20 | 25,000 | 1,555,000 | 528,980 | Mar 24, 2021, 04:41 PM |
Caforio Giovanni | Chairman and CEO | Mar 10, 2021 | Option Exercise | $60.93 | 112,233 | 6,838,357 | 553,980 | Mar 12, 2021, 06:59 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Mar 10, 2021 | Option Exercise | $60.93 | 12,851 | 783,011 | 37,224 | Mar 12, 2021, 06:59 PM |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | Mar 10, 2021 | Option Exercise | $60.93 | 1,910 | 116,376 | 19,362 | Mar 12, 2021, 06:59 PM |
Eid Joseph | SVP,Head Glob. Medical Affairs | Mar 10, 2021 | Option Exercise | $60.93 | 2,192 | 133,559 | 9,187 | Mar 12, 2021, 06:58 PM |
Elkins David V | EVP, Chief Financial Officer | Mar 10, 2021 | Option Exercise | $60.93 | 4,329 | 263,766 | 87,032 | Mar 12, 2021, 06:57 PM |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Mar 10, 2021 | Option Exercise | $60.93 | 1,978 | 120,520 | 7,182 | Mar 12, 2021, 06:56 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2021 | Option Exercise | $60.93 | 31,200 | 1,901,016 | 369,357 | Mar 12, 2021, 06:52 PM |
Powell Ann | EVP, Chief Human Resources | Mar 10, 2021 | Option Exercise | $60.93 | 14,329 | 873,066 | 70,893 | Mar 12, 2021, 06:51 PM |
Santiago Karen Murphy | SVP & Controller | Mar 10, 2021 | Option Exercise | $60.93 | 2,662 | 162,196 | 13,976 | Mar 12, 2021, 06:50 PM |
Schmukler Louis S | EVP,Pres.,Glob.Prod. & Supply | Mar 10, 2021 | Option Exercise | $60.93 | 14,589 | 888,908 | 46,956 | Mar 12, 2021, 06:50 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Mar 10, 2021 | Option Exercise | $60.93 | 3,505 | 213,560 | 75,685 | Mar 12, 2021, 06:50 PM |
von Autenried Paul | EVP, Chief Information Officer | Mar 10, 2021 | Option Exercise | $60.93 | 10,017 | 610,336 | 139,670 | Mar 12, 2021, 06:50 PM |
Elkins David V | EVP, Chief Financial Officer | Mar 01, 2021 | Option Exercise | $61.63 | 8,573 | 528,354 | 83,186 | Mar 03, 2021, 05:27 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Mar 01, 2021 | Option Exercise | $61.63 | 8,944 | 551,219 | 71,628 | Mar 03, 2021, 05:26 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Feb 04, 2021 | Option Exercise | $61.56 | 1,186 | 73,010 | 57,223 | Feb 08, 2021, 07:28 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Dec 31, 2020 | Option Exercise | $62.03 | 13,257 | 822,332 | 54,817 | Jan 05, 2021, 08:14 PM |
Elkins David V | EVP, Chief Financial Officer | Dec 31, 2020 | Option Exercise | $62.03 | 11,931 | 740,080 | 67,180 | Jan 05, 2021, 08:13 PM |
AHMED NADIM | EVP and President, Hematology | Dec 31, 2020 | Option Exercise | $62.03 | 7,660 | 475,150 | 38,889 | Jan 05, 2021, 08:13 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Dec 02, 2020 | Option Exercise | $62.18 | 4,506 | 280,183 | 42,208 | Dec 03, 2020, 08:24 PM |
AHMED NADIM | EVP and President, Hematology | Dec 02, 2020 | Option Exercise | $62.18 | 3,380 | 210,168 | 31,603 | Dec 03, 2020, 08:24 PM |
Elkins David V | EVP, Chief Financial Officer | Dec 02, 2020 | Option Exercise | $62.18 | 5,087 | 316,310 | 58,487 | Dec 03, 2020, 08:24 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Dec 02, 2020 | Option Exercise | $62.18 | 1,299 | 80,772 | 22,371 | Dec 03, 2020, 08:23 PM |
Eid Joseph | SVP,Head Glob. Medical Affairs | Dec 01, 2020 | Option Exercise | $62.41 | 968 | 60,413 | 4,391 | Dec 03, 2020, 05:15 PM |
von Autenried Paul | EVP, Chief Information Officer | Nov 25, 2020 | Sale | $63.50 | 3 | 191 | 126,698 | Nov 30, 2020, 05:52 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Nov 23, 2020 | Sale | $61.34 | 13,421 | 823,244 | 37,922 | Nov 25, 2020, 04:32 PM |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | Nov 24, 2020 | Sale | $63.39 | 900 | 57,051 | 15,186 | Nov 25, 2020, 04:32 PM |
von Autenried Paul | EVP, Chief Information Officer | Nov 24, 2020 | Sale | $62.75 | 20,000 | 1,255,000 | 126,701 | Nov 25, 2020, 04:31 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Nov 19, 2020 | Option Exercise | $49.28 | 52,213 | 2,572,887 | 98,355 | Nov 23, 2020, 05:40 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Nov 19, 2020 | Sale | $61.30 | 57,591 | 3,530,270 | 51,343 | Nov 23, 2020, 05:40 PM |
AHMED NADIM | EVP and President, Hematology | Oct 30, 2020 | Option Exercise | $58.45 | 2,291 | 133,909 | 28,389 | Nov 03, 2020, 04:28 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | Oct 30, 2020 | Option Exercise | $58.45 | 2,859 | 167,109 | 56,721 | Nov 03, 2020, 04:27 PM |
Caforio Giovanni | Chairman and CEO | Aug 31, 2020 | Sale | $62.70 | 39,840 | 2,497,968 | 445,584 | Sep 02, 2020, 04:34 PM |
Santiago Karen Murphy | SVP & Controller | Sep 01, 2020 | Option Exercise | $60.97 | 220 | 13,413 | 8,170 | Sep 02, 2020, 04:33 PM |
Eid Joseph | SVP,Head Glob. Medical Affairs | Aug 17, 2020 | Sale | $64.00 | 5,327 | 340,928 | 2,534 | Aug 19, 2020, 06:15 PM |
LEUNG SANDRA | EVP, General Counsel | Aug 13, 2020 | Sale | $63.24 | 141,420 | 8,943,401 | 432,744 | Aug 17, 2020, 04:55 PM |
Elkins David V | EVP, Chief Financial Officer | Aug 01, 2020 | Option Exercise | $58.66 | 25,916 | 1,520,233 | 54,782 | Aug 04, 2020, 04:43 PM |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Jul 01, 2020 | Option Exercise | $59.43 | 4,463 | 265,236 | 4,893 | Jul 02, 2020, 04:56 PM |
Santiago Karen Murphy | SVP & Controller | Jul 01, 2020 | Option Exercise | $59.43 | 367 | 21,811 | 7,748 | Jul 02, 2020, 04:54 PM |
Paliwal Dinesh C | Director | Jun 15, 2020 | Buy | $54.50 | 9,174 | 499,983 | 22,109 | Jun 16, 2020, 05:15 PM |
BONNEY MICHAEL W | Director | Dec 04, 2019 | Buy | $58.90 | 88 | 5,183 | 7,189 | Jun 09, 2020, 07:16 PM |
Eid Joseph | SVP,Head Glob. Medical Affairs | Jun 03, 2020 | Option Exercise | $60.21 | 738 | 44,435 | 7,861 | Jun 09, 2020, 07:15 PM |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | May 22, 2020 | Sale | $61.01 | 3,200 | 195,232 | 16,086 | May 26, 2020, 05:17 PM |
Schmukler Louis S | EVP,Pres.,Glob.Prod. & Supply | May 19, 2020 | Sale | $62.68 | 25,000 | 1,567,000 | 26,777 | May 21, 2020, 05:22 PM |
VESSEY RUPERT | EVP, Research & Early Dev. | May 01, 2020 | Option Exercise | $60.26 | 5,274 | 317,811 | 53,776 | May 05, 2020, 04:49 PM |
AHMED NADIM | EVP and President, Hematology | May 01, 2020 | Option Exercise | $60.26 | 1,433 | 86,353 | 26,030 | May 05, 2020, 04:49 PM |
von Autenried Paul | EVP, Chief Information Officer | Mar 10, 2020 | Option Exercise | $57.93 | 10,738 | 622,052 | 146,701 | Mar 12, 2020, 06:19 PM |
Schmukler Louis S | EVP,Pres.,Glob.Prod. & Supply | Mar 10, 2020 | Option Exercise | $57.93 | 13,540 | 784,372 | 51,777 | Mar 12, 2020, 06:18 PM |
Santiago Karen Murphy | Controller | Mar 10, 2020 | Option Exercise | $57.93 | 2,017 | 116,845 | 7,046 | Mar 12, 2020, 06:17 PM |
Powell Ann | EVP, Chief Human Resources | Mar 10, 2020 | Option Exercise | $57.93 | 14,462 | 837,784 | 51,452 | Mar 12, 2020, 06:17 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2020 | Option Exercise | $57.93 | 28,312 | 1,640,114 | 574,164 | Mar 12, 2020, 06:15 PM |
Elicker John E | EVP, Investor Relations | Mar 10, 2020 | Option Exercise | $57.93 | 7,860 | 455,330 | 70,946 | Mar 12, 2020, 06:14 PM |
Eid Joseph | SVP,Head Glob. Medical Affairs | Mar 10, 2020 | Option Exercise | $57.93 | 635 | 36,786 | 6,445 | Mar 12, 2020, 06:13 PM |
Eid Joseph | SVP,Head Glob. Medical Affairs | Dec 01, 2019 | Option Exercise | $56.94 | 968 | 55,118 | 5,327 | Mar 12, 2020, 06:13 PM |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | Mar 10, 2020 | Option Exercise | $57.93 | 2,005 | 116,150 | 19,286 | Mar 12, 2020, 06:12 PM |
Caforio Giovanni | Chairman and CEO | Mar 10, 2020 | Option Exercise | $57.93 | 116,943 | 6,774,508 | 485,424 | Mar 12, 2020, 06:11 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Mar 10, 2020 | Option Exercise | $57.68 | 12,167 | 701,756 | 21,033 | Mar 12, 2020, 06:11 PM |
Bancroft Charles A | EVP, Head of Integration | Mar 10, 2020 | Option Exercise | $57.93 | 33,321 | 1,930,286 | 137,534 | Mar 12, 2020, 06:11 PM |
Elicker John E | EVP, Investor Relations | Mar 04, 2020 | Sale | $61.01 | 15,805 | 964,263 | 58,666 | Mar 06, 2020, 05:20 PM |
VESSEY RUPERT | Pres., Research & Early Dev. | Mar 02, 2020 | Option Exercise | $51.69 | 93,468 | 4,831,452 | 132,651 | Mar 04, 2020, 06:19 PM |
VESSEY RUPERT | Pres., Research & Early Dev. | Mar 02, 2020 | Sale | $60.59 | 84,308 | 5,108,222 | 48,343 | Mar 04, 2020, 06:19 PM |
VESSEY RUPERT | Pres., Research & Early Dev. | Mar 01, 2020 | Option Exercise | $59.06 | 8,923 | 526,992 | 39,183 | Mar 03, 2020, 08:05 PM |
Elkins David V | EVP, Chief Financial Officer | Mar 01, 2020 | Option Exercise | $59.06 | 10,470 | 618,358 | 34,296 | Mar 03, 2020, 08:04 PM |
AHMED NADIM | President, Hematology | Mar 01, 2020 | Option Exercise | $59.06 | 8,473 | 500,415 | 24,555 | Mar 03, 2020, 08:04 PM |
VESSEY RUPERT | Pres., Research & Early Dev. | Feb 04, 2020 | Option Exercise | $64.29 | 1,163 | 74,769 | 24,757 | Feb 06, 2020, 08:49 PM |
AHMED NADIM | President, Hematology | Feb 04, 2020 | Option Exercise | $64.29 | 1,071 | 68,855 | 15,824 | Feb 06, 2020, 08:48 PM |
VESSEY RUPERT | Pres., Research & Early Dev. | Dec 31, 2019 | Option Exercise | $64.19 | 7,910 | 507,743 | 22,328 | Jan 15, 2020, 05:04 PM |
VESSEY RUPERT | Pres., Research & Early Dev. | Dec 31, 2019 | Option Exercise | $64.19 | 7,910 | 507,743 | 22,868 | Jan 03, 2020, 07:00 PM |
Elkins David V | EVP, Chief Financial Officer | Dec 31, 2019 | Option Exercise | $64.19 | 6,094 | 391,174 | 20,187 | Jan 03, 2020, 07:00 PM |
Dubow Adam | Chief Compliance & Ethics Offi | Dec 05, 2019 | Sale | $58.81 | 1,740 | 102,329 | 15,749 | Dec 09, 2019, 04:44 PM |
Eid Joseph | SVPHead Global Medical Affairs | Dec 01, 2019 | Option Exercise | $56.94 | 968 | 55,118 | 4,027 | Dec 03, 2019, 05:28 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Nov 05, 2019 | Sale | $56.56 | 25,000 | 1,414,000 | 31,963 | Nov 06, 2019, 04:54 PM |
Elicker John E | SVP, Public Affairs & IR | Nov 05, 2019 | Sale | $56.66 | 15,000 | 849,900 | 74,471 | Nov 06, 2019, 04:54 PM |
Biondi Paul | SVP, Head of Strategy & BD | Oct 02, 2019 | Option Exercise | $49.21 | 203 | 9,990 | 6,214 | Oct 03, 2019, 04:46 PM |
Santiago Karen Murphy | Controller | Sep 01, 2019 | Option Exercise | $48.07 | 220 | 10,575 | 3,487 | Sep 04, 2019, 05:17 PM |
BERTOLINI ROBERT J | Director | Jul 31, 2019 | Buy | $44.72 | 11,000 | 491,920 | 11,397 | Aug 01, 2019, 05:06 PM |
Santiago Karen Murphy | Controller | May 16, 2019 | Sale | $47.56 | 3,065 | 145,771 | 3,066 | May 20, 2019, 04:37 PM |
Samuels Theodore R. II | Director | May 16, 2019 | Buy | $47.29 | 5,000 | 236,440 | 27,000 | May 20, 2019, 04:36 PM |
Caforio Giovanni | Chairman and CEO | May 05, 2019 | Option Exercise | $48.62 | 2,774 | 134,872 | 368,066 | May 06, 2019, 04:40 PM |
Biondi Paul | SVP, Head of Strategy & BD | Oct 02, 2018 | Option Exercise | $62.80 | 292 | 18,338 | 1,041 | May 06, 2019, 04:39 PM |
Lynch Thomas J. Jr. | EVP & Chief Scientific Officer | Apr 03, 2019 | Option Exercise | $46.88 | 6,171 | 289,296 | 22,223 | Apr 05, 2019, 04:32 PM |
Elicker John E | SVP, Public Affairs & IR | Mar 10, 2019 | Option Exercise | $51.39 | 4,540 | 233,311 | 89,471 | Mar 13, 2019, 07:42 AM |
Dubow Adam | Chief Compliance & Ethics Offi | Mar 10, 2019 | Option Exercise | $51.39 | 1,182 | 60,743 | 17,489 | Mar 13, 2019, 07:41 AM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Mar 10, 2019 | Option Exercise | $51.39 | 7,948 | 408,448 | 9,386 | Mar 13, 2019, 07:41 AM |
Caforio Giovanni | Chairman and CEO | Mar 10, 2019 | Option Exercise | $51.39 | 85,912 | 4,415,018 | 365,199 | Mar 13, 2019, 07:40 AM |
Biondi Paul | SVP, Head of Strategy & BD | Mar 10, 2019 | Option Exercise | $51.39 | 3,188 | 163,831 | 5,825 | Mar 13, 2019, 07:39 AM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 10, 2019 | Option Exercise | $51.39 | 24,403 | 1,254,070 | 395,994 | Mar 13, 2019, 07:39 AM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 10, 2019 | Option Exercise | $51.39 | 8,956 | 460,249 | 134,727 | Mar 13, 2019, 07:38 AM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 10, 2019 | Option Exercise | $51.39 | 10,416 | 535,278 | 56,963 | Mar 13, 2019, 07:37 AM |
Santiago Karen Murphy | Controller | Mar 10, 2019 | Option Exercise | $51.39 | 1,196 | 61,462 | 6,131 | Mar 13, 2019, 07:37 AM |
Lynch Thomas J. Jr. | EVP & Chief Scientific Officer | Mar 10, 2019 | Option Exercise | $51.39 | 2,383 | 122,462 | 17,573 | Mar 13, 2019, 07:36 AM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2019 | Option Exercise | $51.39 | 20,205 | 1,038,335 | 546,080 | Mar 13, 2019, 07:35 AM |
JUDGE ANN POWELL | SVP, Global Human Resources | Mar 10, 2019 | Option Exercise | $51.39 | 12,963 | 666,169 | 73,372 | Mar 13, 2019, 07:34 AM |
LEUNG SANDRA | EVP, General Counsel | Feb 28, 2019 | Option Exercise | $51.86 | 109,854 | 5,697,029 | 524,624 | Mar 04, 2019, 12:00 AM |
Bancroft Charles A | EVP & Chief Financial Officer | Feb 28, 2019 | Option Exercise | $51.93 | 29,813 | 1,548,189 | 362,877 | Mar 04, 2019, 12:00 AM |
Bancroft Charles A | EVP & Chief Financial Officer | Feb 28, 2019 | Option Exercise | $17.51 | 52,884 | 925,999 | 392,690 | Mar 04, 2019, 12:00 AM |
LEUNG SANDRA | EVP, General Counsel | Feb 28, 2019 | Option Exercise | $17.51 | 169,893 | 2,974,826 | 634,478 | Mar 04, 2019, 12:00 AM |
Paliwal Dinesh C | Director | Apr 30, 2018 | Buy | $52.40 | 9,540 | 499,896 | 12,935 | Feb 13, 2019, 04:43 PM |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | Feb 02, 2019 | Option Exercise | $49.89 | 1,591 | 79,375 | 2,874 | Feb 05, 2019, 04:53 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Dec 02, 2018 | Option Exercise | $53.46 | 2,716 | 145,197 | 339,806 | Jan 31, 2019, 04:42 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Dec 02, 2018 | Option Exercise | $53.46 | 2,716 | 145,197 | 203,401 | Dec 04, 2018, 04:31 PM |
Biondi Paul | SVP, Head of Strategy & BD | Oct 02, 2018 | Option Exercise | $62.80 | 292 | 18,338 | 300 | Oct 04, 2018, 04:56 PM |
Santiago Karen Murphy | Controller | Sep 01, 2018 | Option Exercise | $60.55 | 220 | 13,321 | 3,837 | Sep 05, 2018, 04:49 PM |
Dubow Adam | Chief Compliance & Ethics Offi | Sep 03, 2018 | Option Exercise | $60.55 | 273 | 16,530 | 15,222 | Sep 05, 2018, 04:49 PM |
Gordon Murdo | EVP, Chief Commercial Officer | Aug 01, 2018 | Option Exercise | $59.62 | 744 | 44,357 | 49,424 | Aug 03, 2018, 05:05 PM |
Biondi Paul | SVP, Head of Strategy & BD | Jul 01, 2018 | Option Exercise | $55.34 | 720 | 39,845 | 741 | Jul 03, 2018, 09:24 PM |
Caforio Giovanni | Chairman and CEO | May 05, 2018 | Option Exercise | $51.33 | 3,146 | 161,484 | 288,033 | May 08, 2018, 05:05 PM |
Paliwal Dinesh C | Director | Apr 30, 2018 | Buy | $52.40 | 4,770 | 249,948 | 8,027 | May 02, 2018, 04:05 PM |
Lynch Thomas J. Jr. | EVP & Chief Scientific Officer | Apr 03, 2018 | Option Exercise | $62.77 | 7,088 | 444,914 | 15,479 | Apr 05, 2018, 04:37 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 10, 2018 | Option Exercise | $67.92 | 14,690 | 997,745 | 42,831 | Mar 13, 2018, 04:57 PM |
Elicker John E | SVP, Public Affairs & IR | Mar 10, 2018 | Option Exercise | $67.92 | 7,811 | 530,523 | 80,968 | Mar 13, 2018, 04:56 PM |
JUDGE ANN POWELL | SVP, Global Human Resources | Mar 10, 2018 | Option Exercise | $67.92 | 18,083 | 1,228,197 | 62,749 | Mar 13, 2018, 04:56 PM |
Caforio Giovanni | Chairman and CEO | Mar 10, 2018 | Option Exercise | $67.92 | 110,895 | 7,531,988 | 290,267 | Mar 13, 2018, 04:56 PM |
Santiago Karen Murphy | Controller | Mar 10, 2018 | Option Exercise | $67.92 | 1,574 | 106,906 | 3,416 | Mar 13, 2018, 04:55 PM |
Gordon Murdo | EVP, Chief Commercial Officer | Mar 10, 2018 | Option Exercise | $67.92 | 20,082 | 1,363,969 | 48,658 | Mar 13, 2018, 04:55 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2018 | Option Exercise | $67.92 | 34,642 | 2,352,885 | 464,585 | Mar 13, 2018, 04:54 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 10, 2018 | Option Exercise | $67.92 | 14,954 | 1,015,676 | 125,264 | Mar 13, 2018, 04:54 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 10, 2018 | Option Exercise | $67.92 | 40,211 | 2,731,131 | 336,121 | Mar 13, 2018, 04:53 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Feb 23, 2018 | Option Exercise | $66.68 | 20,803 | 1,387,144 | 281,545 | Feb 27, 2018, 04:45 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Feb 23, 2018 | Option Exercise | $22.14 | 37,460 | 829,364 | 302,348 | Feb 27, 2018, 04:45 PM |
Samuels Theodore R. II | Director | Dec 15, 2017 | Buy | $62.30 | 4,000 | 249,187 | 22,000 | Dec 18, 2017, 04:21 PM |
Lynch Thomas J. Jr. | EVP & Chief Scientific Officer | Dec 12, 2017 | Sale | $63.24 | 5,300 | 335,172 | 9,251 | Dec 13, 2017, 05:31 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Dec 02, 2017 | Option Exercise | $62.47 | 2,882 | 180,039 | 264,888 | Dec 05, 2017, 06:15 PM |
LEUNG SANDRA | EVP, General Counsel | Dec 04, 2017 | Option Exercise | $22.14 | 156,582 | 3,466,725 | 584,373 | Dec 05, 2017, 06:15 PM |
LEUNG SANDRA | EVP, General Counsel | Dec 04, 2017 | Sale | $63.37 | 156,582 | 9,922,601 | 427,791 | Dec 05, 2017, 06:15 PM |
Elicker John E | SVP, Public Affairs & IR | Nov 01, 2017 | Option Exercise | $62.16 | 223 | 13,862 | 67,943 | Nov 03, 2017, 04:32 PM |
Caldarella Joseph C | SVP & Controller | Sep 06, 2017 | Sale | $60.00 | 9,340 | 560,400 | 46,297 | Sep 08, 2017, 04:31 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Sep 03, 2017 | Option Exercise | $59.81 | 837 | 50,061 | 37,974 | Sep 06, 2017, 04:46 PM |
Samuels Theodore R. II | Director | Aug 02, 2017 | Buy | $55.94 | 6,000 | 335,622 | 18,000 | Aug 03, 2017, 05:08 PM |
Gordon Murdo | EVP, Chief Commercial Officer | Aug 01, 2017 | Option Exercise | $56.10 | 783 | 43,926 | 27,968 | Aug 03, 2017, 05:07 PM |
Caforio Giovanni | Chairman and CEO | May 05, 2017 | Option Exercise | $55.15 | 3,446 | 190,047 | 175,628 | May 09, 2017, 04:32 PM |
ANDREOTTI LAMBERTO | Director | Apr 07, 2017 | Sale | $53.22 | 17,000 | 904,791 | 935,571 | Apr 10, 2017, 05:09 PM |
ANDREOTTI LAMBERTO | Director | Apr 06, 2017 | Sale | $53.29 | 17,000 | 905,964 | 952,571 | Apr 10, 2017, 05:09 PM |
ANDREOTTI LAMBERTO | Director | Mar 31, 2017 | Option Exercise | $54.38 | 459 | 24,960 | 969,571 | Apr 04, 2017, 07:18 PM |
JUDGE ANN POWELL | SVP, Global Human Resources | Apr 01, 2017 | Option Exercise | $54.38 | 700 | 38,066 | 43,425 | Apr 04, 2017, 07:17 PM |
ANDREOTTI LAMBERTO | Director | Mar 28, 2017 | Sale | $56.20 | 17,000 | 955,369 | 969,112 | Mar 29, 2017, 06:19 PM |
ANDREOTTI LAMBERTO | Director | Mar 27, 2017 | Sale | $56.14 | 17,000 | 954,451 | 986,112 | Mar 29, 2017, 06:19 PM |
Caldarella Joseph C | SVP & Controller | Mar 15, 2017 | Sale | $57.28 | 8,096 | 463,779 | 55,637 | Mar 22, 2017, 06:20 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 17, 2017 | Sale | $56.49 | 5,000 | 282,470 | 21,483 | Mar 21, 2017, 04:35 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 14, 2017 | Sale | $56.75 | 15,000 | 851,220 | 26,483 | Mar 16, 2017, 04:37 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2017 | Option Exercise | $58.32 | 34,495 | 2,011,748 | 427,791 | Mar 14, 2017, 08:33 PM |
Cuss Francis M | EVP & CSO | Mar 10, 2017 | Option Exercise | $58.32 | 34,452 | 2,009,241 | 321,906 | Mar 14, 2017, 08:33 PM |
Blin Emmanuel | SVP, Chief Strategy Officer | Mar 10, 2017 | Option Exercise | $58.32 | 5,530 | 322,510 | 20,138 | Mar 14, 2017, 08:32 PM |
Caforio Giovanni | Chief Executive Officer | Mar 10, 2017 | Option Exercise | $58.32 | 44,782 | 2,611,686 | 172,418 | Mar 14, 2017, 08:32 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 10, 2017 | Option Exercise | $58.32 | 40,008 | 2,333,267 | 261,369 | Mar 14, 2017, 08:31 PM |
Gordon Murdo | EVP, Chief Commercial Officer | Mar 10, 2017 | Option Exercise | $58.32 | 12,817 | 747,487 | 27,241 | Mar 14, 2017, 08:31 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 10, 2017 | Option Exercise | $58.32 | 15,501 | 904,018 | 108,130 | Mar 14, 2017, 08:31 PM |
ANDREOTTI LAMBERTO | Director | Mar 10, 2017 | Option Exercise | $58.32 | 56,993 | 3,323,832 | 1,003,112 | Mar 14, 2017, 08:30 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 10, 2017 | Option Exercise | $58.32 | 5,434 | 316,911 | 37,217 | Mar 14, 2017, 08:30 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 10, 2017 | Option Exercise | $58.32 | 14,452 | 842,841 | 41,483 | Mar 14, 2017, 08:30 PM |
Elicker John E | SVP, Public Affairs & IR | Mar 10, 2017 | Option Exercise | $58.32 | 7,577 | 441,891 | 67,672 | Mar 14, 2017, 08:29 PM |
JUDGE ANN POWELL | SVP, Global Human Resources | Mar 10, 2017 | Option Exercise | $58.32 | 13,892 | 810,181 | 42,571 | Mar 14, 2017, 08:29 PM |
Caldarella Joseph C | SVP & Controller | Mar 10, 2017 | Option Exercise | $58.32 | 7,594 | 442,882 | 63,733 | Mar 14, 2017, 08:29 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 03, 2017 | Option Exercise | $27.01 | 116,100 | 3,135,861 | 488,063 | Mar 07, 2017, 04:39 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 06, 2017 | Sale | $57.02 | 92,405 | 5,268,563 | 395,658 | Mar 07, 2017, 04:39 PM |
Samuels Theodore R. II | Director | Feb 27, 2017 | Buy | $56.77 | 12,000 | 681,240 | 12,000 | Mar 01, 2017, 04:47 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Feb 28, 2017 | Option Exercise | $27.01 | 22,598 | 610,372 | 212,516 | Mar 01, 2017, 04:47 PM |
ANDREOTTI LAMBERTO | Director | Jan 30, 2017 | Option Exercise | $27.01 | 100,000 | 2,701,000 | 957,931 | Feb 01, 2017, 04:43 PM |
Elicker John E | SVP, Public Affairs & IR | Jan 03, 2017 | Option Exercise | $58.44 | 340 | 19,870 | 55,892 | Jan 05, 2017, 04:37 PM |
ANDREOTTI LAMBERTO | Director | Dec 31, 2016 | Option Exercise | $58.44 | 427 | 24,954 | 857,931 | Jan 04, 2017, 08:20 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Dec 02, 2016 | Option Exercise | $55.96 | 2,883 | 161,333 | 189,918 | Dec 06, 2016, 05:21 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Dec 02, 2016 | Option Exercise | $55.96 | 2,883 | 161,333 | 189,918 | Dec 06, 2016, 04:42 PM |
ANDREOTTI LAMBERTO | Director | Nov 01, 2016 | Option Exercise | $22.14 | 305,909 | 6,772,825 | 998,777 | Nov 03, 2016, 05:22 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Nov 01, 2016 | Option Exercise | $50.80 | 1,396 | 70,917 | 186,398 | Nov 03, 2016, 05:21 PM |
Elicker John E | SVP, Public Affairs & IR | Nov 01, 2016 | Option Exercise | $50.80 | 223 | 11,328 | 55,282 | Nov 03, 2016, 05:21 PM |
ANDREOTTI LAMBERTO | Director | Oct 11, 2016 | Option Exercise | $17.51 | 368,706 | 6,456,042 | 692,868 | Oct 13, 2016, 05:00 PM |
ANDREOTTI LAMBERTO | Director | Sep 30, 2016 | Option Exercise | $53.92 | 463 | 24,965 | 324,162 | Oct 04, 2016, 05:50 PM |
ANDREOTTI LAMBERTO | Director | Sep 08, 2016 | Sale | $56.97 | 10,800 | 615,276 | 323,699 | Sep 09, 2016, 04:41 PM |
ANDREOTTI LAMBERTO | Director | Sep 07, 2016 | Sale | $56.77 | 10,800 | 613,116 | 334,499 | Sep 09, 2016, 04:41 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Sep 03, 2016 | Option Exercise | $56.96 | 849 | 48,359 | 28,873 | Sep 07, 2016, 04:33 PM |
ANDREOTTI LAMBERTO | Director | Aug 25, 2016 | Sale | $58.92 | 11,600 | 683,472 | 345,299 | Aug 25, 2016, 05:10 PM |
ANDREOTTI LAMBERTO | Director | Aug 24, 2016 | Sale | $59.43 | 11,600 | 689,359 | 364,999 | Aug 25, 2016, 05:10 PM |
Gordon Murdo | EVP, Chief Commercial Officer | Aug 01, 2016 | Option Exercise | $76.19 | 784 | 59,733 | 14,466 | Aug 03, 2016, 04:56 PM |
ANDREOTTI LAMBERTO | Director | Jul 08, 2016 | Sale | $75.04 | 11,600 | 870,461 | 374,199 | Jul 11, 2016, 05:12 PM |
ANDREOTTI LAMBERTO | Director | Jul 07, 2016 | Sale | $73.86 | 11,600 | 856,776 | 380,099 | Jul 11, 2016, 05:12 PM |
Cuss Francis M | EVP & CSO | Jul 01, 2016 | Option Exercise | $73.78 | 1,896 | 139,887 | 289,732 | Jul 06, 2016, 05:58 PM |
Gordon Murdo | EVP, Chief Commercial Officer | Jul 01, 2016 | Option Exercise | $73.78 | 1,211 | 89,348 | 13,739 | Jul 06, 2016, 05:58 PM |
Blin Emmanuel | SVP, Chief Strategy Officer | Jul 02, 2016 | Option Exercise | $73.78 | 219 | 16,158 | 12,297 | Jul 06, 2016, 05:58 PM |
ANDREOTTI LAMBERTO | Director | Jun 30, 2016 | Option Exercise | $73.55 | 474 | 34,863 | 391,699 | Jul 05, 2016, 06:09 PM |
ANDREOTTI LAMBERTO | Director | Mar 31, 2016 | Option Exercise | $63.88 | 831 | 53,084 | 460,825 | Jul 05, 2016, 06:07 PM |
ANDREOTTI LAMBERTO | Director | Jun 29, 2016 | Sale | $72.79 | 9,800 | 713,342 | 392,194 | Jun 30, 2016, 05:42 PM |
ANDREOTTI LAMBERTO | Director | Jun 28, 2016 | Sale | $71.67 | 13,400 | 960,396 | 403,094 | Jun 30, 2016, 05:42 PM |
Elicker John E | SVP, Public Affairs & IR | Jun 14, 2016 | Sale | $72.69 | 11,820 | 859,219 | 55,011 | Jun 16, 2016, 04:31 PM |
Bancroft Charles A | EVP & Chief Financial Officer | May 20, 2016 | Sale | $70.79 | 30,201 | 2,137,838 | 184,694 | May 24, 2016, 05:04 PM |
Caldarella Joseph C | SVP & Controller | May 16, 2016 | Sale | $72.46 | 3,519 | 255,004 | 55,238 | May 17, 2016, 04:46 PM |
LEUNG SANDRA | EVP, General Counsel | May 06, 2016 | Option Exercise | $24.74 | 100,000 | 2,474,000 | 444,507 | May 10, 2016, 04:35 PM |
LEUNG SANDRA | EVP, General Counsel | May 06, 2016 | Sale | $70.39 | 72,544 | 5,106,372 | 371,963 | May 10, 2016, 04:35 PM |
Caforio Giovanni | Chief Executive Officer | May 05, 2016 | Option Exercise | $70.78 | 4,500 | 318,510 | 130,701 | May 09, 2016, 04:42 PM |
ANDREOTTI LAMBERTO | Director | May 04, 2016 | Sale | $70.48 | 11,600 | 817,568 | 425,194 | May 06, 2016, 04:53 PM |
ANDREOTTI LAMBERTO | Director | May 05, 2016 | Sale | $70.59 | 11,600 | 818,844 | 413,594 | May 06, 2016, 04:53 PM |
Caforio Giovanni | Chief Executive Officer | May 03, 2016 | Option Exercise | $24.79 | 50,455 | 1,250,602 | 145,958 | May 05, 2016, 04:31 PM |
Caforio Giovanni | Chief Executive Officer | May 03, 2016 | Sale | $71.31 | 34,594 | 2,466,885 | 126,509 | May 05, 2016, 04:31 PM |
Nielsen Anne | Chief Compliance & Ethics Off | May 02, 2016 | Sale | $71.88 | 28,451 | 2,045,172 | 28,126 | May 04, 2016, 05:29 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | May 02, 2016 | Option Exercise | $17.51 | 51,504 | 901,835 | 128,463 | May 04, 2016, 05:29 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | May 02, 2016 | Sale | $71.93 | 37,258 | 2,679,819 | 91,205 | May 04, 2016, 05:29 PM |
ANDREOTTI LAMBERTO | Director | May 02, 2016 | Option Exercise | $26.04 | 234,720 | 6,112,787 | 671,514 | May 04, 2016, 05:28 PM |
ANDREOTTI LAMBERTO | Director | May 02, 2016 | Sale | $71.88 | 234,720 | 16,870,792 | 571,514 | May 04, 2016, 05:28 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | May 02, 2016 | Sale | $71.95 | 22,218 | 1,598,652 | 21,971 | May 04, 2016, 05:28 PM |
ANDREOTTI LAMBERTO | Director | Apr 05, 2016 | Sale | $66.00 | 11,600 | 765,626 | 436,994 | Apr 06, 2016, 04:18 PM |
ANDREOTTI LAMBERTO | Director | Apr 04, 2016 | Sale | $65.79 | 11,600 | 763,216 | 453,094 | Apr 06, 2016, 04:18 PM |
JUDGE ANN POWELL | SVP, Global Human Resources | Apr 01, 2016 | Option Exercise | $64.91 | 700 | 45,437 | 24,560 | Apr 05, 2016, 04:59 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 10, 2016 | Option Exercise | $64.94 | 36,427 | 2,365,569 | 214,895 | Mar 23, 2016, 04:03 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 10, 2016 | Option Exercise | $64.94 | 15,235 | 989,361 | 44,189 | Mar 14, 2016, 09:44 PM |
Caldarella Joseph C | SVP & Controller | Mar 10, 2016 | Option Exercise | $64.94 | 11,654 | 756,811 | 58,757 | Mar 14, 2016, 09:44 PM |
Elicker John E | SVP, Public Affairs & IR | Mar 10, 2016 | Option Exercise | $64.94 | 9,571 | 621,541 | 66,831 | Mar 14, 2016, 09:43 PM |
ANDREOTTI LAMBERTO | Director | Mar 10, 2016 | Option Exercise | $64.94 | 114,107 | 7,410,109 | 459,994 | Mar 14, 2016, 09:43 PM |
Cuss Francis M | EVP & CSO | Mar 10, 2016 | Option Exercise | $64.94 | 20,586 | 1,336,855 | 287,973 | Mar 14, 2016, 09:43 PM |
JUDGE ANN POWELL | SVP, Global Human Resources | Mar 10, 2016 | Option Exercise | $64.94 | 11,835 | 768,565 | 23,706 | Mar 14, 2016, 09:43 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 10, 2016 | Option Exercise | $64.94 | 31,789 | 2,064,378 | 344,507 | Mar 14, 2016, 09:42 PM |
Caforio Giovanni | Chief Executive Officer | Mar 10, 2016 | Option Exercise | $64.94 | 33,486 | 2,174,581 | 110,648 | Mar 14, 2016, 09:42 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 10, 2016 | Option Exercise | $64.94 | 17,218 | 1,118,137 | 76,959 | Mar 14, 2016, 09:42 PM |
Blin Emmanuel | SVP, Head of Commercialization | Mar 10, 2016 | Option Exercise | $64.94 | 2,873 | 186,573 | 11,565 | Mar 14, 2016, 09:42 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 10, 2016 | Option Exercise | $64.94 | 36,427 | 2,365,569 | 221,724 | Mar 14, 2016, 09:41 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 10, 2016 | Option Exercise | $64.94 | 3,809 | 247,356 | 56,577 | Mar 14, 2016, 09:41 PM |
Gordon Murdo | SVP, Head of Worldwide Markets | Mar 10, 2016 | Option Exercise | $64.94 | 10,675 | 693,235 | 12,615 | Mar 14, 2016, 09:41 PM |
CAMPBELL LEWIS B | Director | Mar 08, 2016 | Option Exercise | $24.96 | 2,500 | 62,400 | 2,500 | Mar 10, 2016, 04:36 PM |
CAMPBELL LEWIS B | Director | Mar 08, 2016 | Sale | $66.00 | 2,500 | 165,000 | 0 | Mar 10, 2016, 04:36 PM |
ANDREOTTI LAMBERTO | Director | Mar 09, 2016 | Sale | $65.37 | 11,600 | 758,260 | 369,854 | Mar 10, 2016, 04:36 PM |
ANDREOTTI LAMBERTO | Director | Mar 08, 2016 | Sale | $66.06 | 11,600 | 766,296 | 381,254 | Mar 10, 2016, 04:36 PM |
Caldarella Joseph C | SVP & Controller | Mar 06, 2016 | Option Exercise | $64.71 | 1,554 | 100,559 | 48,536 | Mar 08, 2016, 04:43 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 06, 2016 | Option Exercise | $64.71 | 546 | 35,332 | 50,964 | Mar 08, 2016, 04:43 PM |
Gordon Murdo | SVP, Head of Worldwide Markets | Mar 06, 2016 | Option Exercise | $64.71 | 1,125 | 72,799 | 2,706 | Mar 08, 2016, 04:43 PM |
Caforio Giovanni | Chief Executive Officer | Mar 06, 2016 | Option Exercise | $64.71 | 2,919 | 188,888 | 79,457 | Mar 08, 2016, 04:42 PM |
Cuss Francis M | EVP & CSO | Mar 06, 2016 | Option Exercise | $64.71 | 3,046 | 197,107 | 268,861 | Mar 08, 2016, 04:42 PM |
Elicker John E | SVP, Public Affairs & IR | Mar 06, 2016 | Option Exercise | $64.71 | 620 | 40,120 | 54,087 | Mar 08, 2016, 04:41 PM |
LEUNG SANDRA | EVP, General Counsel | Mar 06, 2016 | Option Exercise | $64.71 | 5,623 | 363,864 | 314,801 | Mar 08, 2016, 04:41 PM |
Blin Emmanuel | SVP, Head of Commercialization | Mar 06, 2016 | Option Exercise | $64.71 | 368 | 23,813 | 1,964 | Mar 08, 2016, 04:41 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 06, 2016 | Option Exercise | $64.71 | 6,435 | 416,409 | 170,418 | Mar 08, 2016, 04:40 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 06, 2016 | Option Exercise | $64.71 | 1,739 | 112,531 | 60,568 | Mar 08, 2016, 04:40 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 06, 2016 | Option Exercise | $64.71 | 1,562 | 101,077 | 25,589 | Mar 08, 2016, 04:40 PM |
Caldarella Joseph C | SVP & Controller | Mar 04, 2016 | Sale | $64.64 | 12,962 | 837,915 | 46,322 | Mar 07, 2016, 05:41 PM |
Caforio Giovanni | Chief Executive Officer | Feb 17, 2016 | Option Exercise | $22.89 | 20,125 | 460,661 | 88,778 | Feb 19, 2016, 04:32 PM |
Caforio Giovanni | Chief Executive Officer | Feb 17, 2016 | Sale | $63.58 | 12,040 | 765,527 | 76,738 | Feb 19, 2016, 04:32 PM |
LEUNG SANDRA | EVP, General Counsel | Feb 17, 2016 | Option Exercise | $22.73 | 14,560 | 330,949 | 319,699 | Feb 19, 2016, 04:32 PM |
LEUNG SANDRA | EVP, General Counsel | Feb 17, 2016 | Sale | $63.57 | 10,152 | 645,342 | 309,547 | Feb 19, 2016, 04:32 PM |
ANDREOTTI LAMBERTO | Director | Feb 12, 2016 | Sale | $59.71 | 11,600 | 692,649 | 393,354 | Feb 16, 2016, 04:32 PM |
ANDREOTTI LAMBERTO | Director | Feb 11, 2016 | Sale | $59.52 | 11,600 | 690,374 | 404,754 | Feb 16, 2016, 04:32 PM |
ANDREOTTI LAMBERTO | Director | Feb 04, 2016 | Option Exercise | $59.70 | 128,119 | 7,648,704 | 416,054 | Feb 08, 2016, 04:31 PM |
ANDREOTTI LAMBERTO | Director | Jan 05, 2016 | Sale | $68.19 | 11,600 | 791,028 | 311,024 | Jan 06, 2016, 04:40 PM |
ANDREOTTI LAMBERTO | Director | Jan 04, 2016 | Sale | $66.93 | 11,600 | 776,332 | 322,124 | Jan 06, 2016, 04:40 PM |
ANDREOTTI LAMBERTO | Director | Dec 31, 2015 | Option Exercise | $68.79 | 772 | 53,106 | 333,624 | Jan 05, 2016, 06:21 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Jan 03, 2016 | Option Exercise | $68.79 | 340 | 23,389 | 52,672 | Jan 05, 2016, 06:21 PM |
ANDREOTTI LAMBERTO | Director | Dec 15, 2015 | Sale | $70.05 | 11,600 | 812,580 | 332,852 | Dec 16, 2015, 04:39 PM |
ANDREOTTI LAMBERTO | Director | Dec 14, 2015 | Sale | $68.00 | 11,600 | 788,843 | 344,752 | Dec 16, 2015, 04:39 PM |
ANDREOTTI LAMBERTO | Director | Nov 19, 2015 | Sale | $67.02 | 11,600 | 777,470 | 512,852 | Nov 23, 2015, 04:41 PM |
ANDREOTTI LAMBERTO | Director | Nov 20, 2015 | Sale | $67.76 | 11,600 | 786,016 | 501,052 | Nov 23, 2015, 04:41 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Nov 01, 2015 | Option Exercise | $65.75 | 224 | 14,728 | 52,062 | Nov 03, 2015, 03:45 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Nov 01, 2015 | Option Exercise | $65.75 | 1,396 | 91,787 | 162,561 | Nov 03, 2015, 03:45 PM |
ANDREOTTI LAMBERTO | Director | Oct 05, 2015 | Sale | $61.99 | 11,600 | 719,027 | 537,552 | Oct 08, 2015, 04:08 PM |
ANDREOTTI LAMBERTO | Director | Oct 06, 2015 | Sale | $59.73 | 11,600 | 692,904 | 532,652 | Oct 08, 2015, 04:08 PM |
ANDREOTTI LAMBERTO | Director | Sep 30, 2015 | Option Exercise | $59.20 | 578 | 34,218 | 547,452 | Oct 02, 2015, 04:31 PM |
ANDREOTTI LAMBERTO | Director | Sep 03, 2015 | Sale | $59.57 | 11,600 | 691,032 | 552,974 | Sep 03, 2015, 06:34 PM |
ANDREOTTI LAMBERTO | Director | Sep 02, 2015 | Sale | $59.22 | 11,600 | 687,005 | 569,974 | Sep 03, 2015, 06:34 PM |
ANDREOTTI LAMBERTO | Director | Aug 03, 2015 | Option Exercise | $24.01 | 315,000 | 7,561,950 | 885,074 | Aug 05, 2015, 04:57 PM |
ANDREOTTI LAMBERTO | Director | Aug 03, 2015 | Sale | $65.36 | 315,000 | 20,589,328 | 853,874 | Aug 05, 2015, 04:57 PM |
Blin Emmanuel | SVP, Head of Commercialization | Jul 02, 2015 | Option Exercise | $67.48 | 219 | 14,778 | 734 | Jul 07, 2015, 05:13 PM |
Gordon Murdo | SVP, Head of Worldwide Markets | Jul 01, 2015 | Option Exercise | $67.67 | 1,211 | 81,948 | 1,329 | Jul 06, 2015, 07:17 PM |
Caldarella Joseph C | SVP & Controller | Jun 04, 2015 | Sale | $65.71 | 16,972 | 1,115,229 | 76,184 | Jun 08, 2015, 04:17 PM |
JUDGE ANN POWELL | SVP, Global Human Resources | Apr 01, 2015 | Option Exercise | $63.56 | 700 | 44,492 | 8,347 | Apr 03, 2015, 03:39 PM |
CORNELIUS JAMES M | Director | Mar 31, 2015 | Option Exercise | $64.50 | 387 | 24,962 | 79,851 | Apr 02, 2015, 05:52 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 10, 2015 | Option Exercise | $65.53 | 8,113 | 531,645 | 160,857 | Mar 23, 2015, 05:01 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 10, 2015 | Option Exercise | $65.53 | 38,295 | 2,509,471 | 570,074 | Mar 23, 2015, 05:01 PM |
Cuss Francis M | EVP & CSO | Mar 16, 2015 | Option Exercise | $25.52 | 114,010 | 2,909,160 | 380,699 | Mar 17, 2015, 05:54 PM |
Cuss Francis M | EVP & CSO | Mar 16, 2015 | Sale | $67.81 | 114,666 | 7,775,501 | 266,033 | Mar 17, 2015, 05:54 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 16, 2015 | Sale | $67.08 | 7,000 | 469,560 | 22,218 | Mar 16, 2015, 07:02 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 13, 2015 | Sale | $66.79 | 5,000 | 333,972 | 33,618 | Mar 16, 2015, 07:02 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 13, 2015 | Sale | $66.67 | 591 | 39,402 | 31,015 | Mar 16, 2015, 07:01 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 10, 2015 | Option Exercise | $65.53 | 38,295 | 2,509,471 | 400,858 | Mar 12, 2015, 06:56 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 10, 2015 | Option Exercise | $65.53 | 8,113 | 531,645 | 181,609 | Mar 12, 2015, 06:55 PM |
Caldarella Joseph C | SVP & Controller | Mar 10, 2015 | Option Exercise | $65.53 | 2,391 | 156,682 | 76,256 | Mar 12, 2015, 06:55 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 10, 2015 | Option Exercise | $65.53 | 3,739 | 245,017 | 57,641 | Mar 12, 2015, 06:55 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 10, 2015 | Option Exercise | $65.53 | 969 | 63,499 | 50,097 | Mar 12, 2015, 06:55 PM |
Caforio Giovanni | Chief Operating Officer | Mar 10, 2015 | Option Exercise | $65.53 | 7,401 | 484,988 | 68,653 | Mar 12, 2015, 06:54 PM |
Cuss Francis M | EVP & CSO | Mar 10, 2015 | Option Exercise | $65.53 | 5,347 | 350,389 | 266,689 | Mar 12, 2015, 06:54 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 10, 2015 | Option Exercise | $65.53 | 1,835 | 120,248 | 51,790 | Mar 12, 2015, 06:54 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 10, 2015 | Option Exercise | $65.53 | 3,283 | 215,135 | 34,218 | Mar 12, 2015, 06:54 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 10, 2015 | Option Exercise | $65.53 | 1,507 | 98,754 | 41,949 | Mar 12, 2015, 06:53 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 10, 2015 | Sale | $65.84 | 10,343 | 680,942 | 31,606 | Mar 12, 2015, 06:53 PM |
JUDGE ANN POWELL | SVP, Human Resources | Mar 10, 2015 | Option Exercise | $65.53 | 1,865 | 122,213 | 7,493 | Mar 12, 2015, 06:53 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 10, 2015 | Option Exercise | $65.53 | 7,067 | 463,101 | 305,139 | Mar 12, 2015, 06:53 PM |
Cuss Francis M | EVP & CSO | Mar 06, 2015 | Option Exercise | $65.12 | 3,014 | 196,272 | 261,725 | Mar 10, 2015, 04:54 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 06, 2015 | Option Exercise | $65.12 | 2,393 | 155,832 | 54,171 | Mar 10, 2015, 04:53 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 06, 2015 | Option Exercise | $65.12 | 579 | 37,704 | 48,726 | Mar 10, 2015, 04:53 PM |
Caldarella Joseph C | SVP & Controller | Mar 06, 2015 | Option Exercise | $65.12 | 2,088 | 135,971 | 74,378 | Mar 10, 2015, 04:53 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 06, 2015 | Option Exercise | $65.12 | 613 | 39,919 | 59,499 | Mar 10, 2015, 04:53 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 06, 2015 | Sale | $66.24 | 10,468 | 693,452 | 54,160 | Mar 10, 2015, 04:53 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 06, 2015 | Option Exercise | $65.12 | 5,581 | 363,435 | 298,578 | Mar 10, 2015, 04:52 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 06, 2015 | Option Exercise | $65.12 | 6,367 | 414,619 | 171,702 | Mar 10, 2015, 04:52 PM |
Caforio Giovanni | Chief Operating Officer | Mar 06, 2015 | Option Exercise | $65.12 | 2,893 | 188,392 | 61,783 | Mar 10, 2015, 04:52 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 06, 2015 | Option Exercise | $65.12 | 2,198 | 143,134 | 30,209 | Mar 10, 2015, 04:52 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 06, 2015 | Option Exercise | $65.12 | 31,525 | 2,052,908 | 370,563 | Mar 10, 2015, 04:51 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 06, 2015 | Option Exercise | $65.12 | 1,045 | 68,050 | 40,550 | Mar 10, 2015, 04:51 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 02, 2015 | Option Exercise | $62.30 | 22,858 | 1,424,053 | 293,397 | Mar 04, 2015, 09:39 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 02, 2015 | Option Exercise | $62.30 | 6,651 | 414,357 | 27,525 | Mar 04, 2015, 09:38 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 02, 2015 | Option Exercise | $62.30 | 4,279 | 266,582 | 39,581 | Mar 04, 2015, 09:38 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 02, 2015 | Option Exercise | $62.30 | 2,511 | 156,435 | 58,098 | Mar 04, 2015, 09:38 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 02, 2015 | Option Exercise | $62.30 | 2,370 | 147,651 | 47,908 | Mar 04, 2015, 09:37 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 02, 2015 | Option Exercise | $62.30 | 8,474 | 527,930 | 51,949 | Mar 04, 2015, 09:37 PM |
Cuss Francis M | EVP & CSO | Mar 02, 2015 | Option Exercise | $62.30 | 11,177 | 696,327 | 258,928 | Mar 04, 2015, 09:37 PM |
Caforio Giovanni | Chief Operating Officer | Mar 02, 2015 | Option Exercise | $62.30 | 11,028 | 687,044 | 59,097 | Mar 04, 2015, 09:37 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 02, 2015 | Option Exercise | $62.30 | 129,125 | 8,044,487 | 514,839 | Mar 04, 2015, 09:36 PM |
Caldarella Joseph C | SVP & Controller | Mar 02, 2015 | Option Exercise | $62.30 | 6,993 | 435,664 | 72,737 | Mar 04, 2015, 09:36 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 02, 2015 | Option Exercise | $62.30 | 26,080 | 1,624,784 | 144,434 | Mar 04, 2015, 09:36 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 02, 2015 | Option Exercise | $62.30 | 2,371 | 147,713 | 41,516 | Mar 04, 2015, 05:14 PM |
Cuss Francis M | EVP & CSO | Mar 02, 2015 | Option Exercise | $62.30 | 2,759 | 171,886 | 246,302 | Mar 04, 2015, 05:14 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 02, 2015 | Option Exercise | $62.30 | 6,433 | 400,776 | 111,330 | Mar 04, 2015, 05:14 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 02, 2015 | Option Exercise | $62.30 | 844 | 52,581 | 44,552 | Mar 04, 2015, 05:14 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 02, 2015 | Option Exercise | $62.30 | 37,441 | 2,332,574 | 412,684 | Mar 04, 2015, 05:13 PM |
Caforio Giovanni | Chief Operating Officer | Mar 02, 2015 | Option Exercise | $62.30 | 1,114 | 69,402 | 47,273 | Mar 04, 2015, 05:13 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 02, 2015 | Option Exercise | $62.30 | 1,218 | 75,881 | 35,610 | Mar 04, 2015, 05:13 PM |
Caldarella Joseph C | SVP & Controller | Mar 02, 2015 | Option Exercise | $62.30 | 2,041 | 127,154 | 64,459 | Mar 04, 2015, 05:13 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 02, 2015 | Option Exercise | $62.30 | 828 | 51,584 | 52,359 | Mar 04, 2015, 05:12 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 02, 2015 | Option Exercise | $62.30 | 6,575 | 409,622 | 272,171 | Mar 04, 2015, 05:12 PM |
LEUNG SANDRA | General Counsel & Secretary | Feb 17, 2015 | Option Exercise | $25.45 | 15,000 | 381,750 | 275,656 | Feb 18, 2015, 05:32 PM |
LEUNG SANDRA | General Counsel & Secretary | Feb 17, 2015 | Sale | $60.38 | 11,746 | 709,282 | 263,910 | Feb 18, 2015, 05:32 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Feb 12, 2015 | Sale | $59.26 | 3,880 | 229,933 | 34,480 | Feb 13, 2015, 04:38 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Feb 06, 2015 | Option Exercise | $22.14 | 27,938 | 618,547 | 59,838 | Feb 10, 2015, 06:11 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Feb 06, 2015 | Sale | $60.15 | 21,478 | 1,291,988 | 38,360 | Feb 10, 2015, 06:11 PM |
CORNELIUS JAMES M | Director | Jan 30, 2015 | Sale | $60.60 | 50,000 | 3,029,975 | 119,464 | Feb 03, 2015, 06:18 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Jan 29, 2015 | Sale | $60.73 | 5,250 | 318,850 | 14,182 | Feb 02, 2015, 07:05 PM |
CAMPBELL LEWIS B | Director | Jan 29, 2015 | Option Exercise | $26.25 | 2,500 | 65,625 | 2,500 | Feb 02, 2015, 07:05 PM |
CAMPBELL LEWIS B | Director | Jan 29, 2015 | Sale | $60.89 | 2,500 | 152,227 | 200 | Feb 02, 2015, 07:05 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Jan 29, 2015 | Option Exercise | $25.45 | 112,500 | 2,863,125 | 473,309 | Feb 02, 2015, 07:05 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Jan 29, 2015 | Sale | $61.14 | 90,246 | 5,518,002 | 383,063 | Feb 02, 2015, 07:05 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Jan 03, 2015 | Option Exercise | $59.51 | 341 | 20,293 | 50,467 | Jan 06, 2015, 06:56 PM |
Caforio Giovanni | Chief Operating Officer | Jan 03, 2015 | Option Exercise | $59.51 | 2,855 | 169,901 | 45,399 | Jan 06, 2015, 06:56 PM |
CORNELIUS JAMES M | Director | Dec 31, 2014 | Option Exercise | $59.03 | 423 | 24,970 | 169,464 | Jan 05, 2015, 07:38 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Dec 05, 2014 | Sale | $60.31 | 75,000 | 4,522,944 | 426,113 | Dec 05, 2014, 05:39 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Nov 05, 2014 | Sale | $57.79 | 75,000 | 4,334,153 | 435,809 | Nov 07, 2014, 05:13 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Nov 01, 2014 | Option Exercise | $58.19 | 1,397 | 81,291 | 98,269 | Nov 04, 2014, 05:43 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Oct 24, 2014 | Sale | $53.00 | 50,000 | 2,650,000 | 510,809 | Oct 28, 2014, 04:23 PM |
CORNELIUS JAMES M | Director | Oct 15, 2014 | Sale | $48.92 | 100,000 | 4,892,000 | 169,041 | Oct 17, 2014, 05:16 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Oct 06, 2014 | Sale | $50.99 | 50,000 | 2,549,485 | 560,809 | Oct 08, 2014, 06:02 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Oct 03, 2014 | Option Exercise | $50.85 | 6,133 | 311,863 | 19,432 | Oct 06, 2014, 05:52 PM |
CORNELIUS JAMES M | Director | Sep 30, 2014 | Option Exercise | $51.18 | 488 | 24,976 | 269,041 | Oct 02, 2014, 04:44 PM |
Caforio Giovanni | Chief Operating Officer | Sep 15, 2014 | Sale | $49.87 | 26,691 | 1,331,155 | 40,755 | Sep 16, 2014, 05:18 PM |
Cuss Francis M | EVP & CSO | Sep 16, 2014 | Option Exercise | $25.17 | 63,667 | 1,602,575 | 302,113 | Sep 16, 2014, 05:18 PM |
Cuss Francis M | EVP & CSO | Sep 16, 2014 | Sale | $50.77 | 63,667 | 3,232,074 | 238,446 | Sep 16, 2014, 05:18 PM |
Caldarella Joseph C | SVP & Controller | Sep 10, 2014 | Sale | $51.03 | 7,415 | 378,377 | 65,850 | Sep 10, 2014, 04:30 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Sep 08, 2014 | Sale | $51.05 | 50,000 | 2,552,430 | 610,809 | Sep 10, 2014, 04:30 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Aug 19, 2014 | Sale | $49.89 | 20,000 | 997,851 | 42,514 | Aug 19, 2014, 05:08 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Jul 29, 2014 | Sale | $51.06 | 67,621 | 3,452,532 | 96,564 | Jul 30, 2014, 04:42 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Jul 28, 2014 | Option Exercise | $27.01 | 19,650 | 530,747 | 59,652 | Jul 30, 2014, 04:40 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Jul 28, 2014 | Sale | $49.32 | 25,752 | 1,270,037 | 33,900 | Jul 30, 2014, 04:40 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Jul 01, 2014 | Option Exercise | $48.12 | 2,103 | 101,196 | 94,374 | Jul 02, 2014, 06:35 PM |
CORNELIUS JAMES M | Director | Jun 30, 2014 | Option Exercise | $48.51 | 515 | 24,983 | 268,553 | Jul 02, 2014, 06:02 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | May 05, 2014 | Option Exercise | $49.80 | 15,650 | 779,370 | 660,809 | May 06, 2014, 09:17 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | May 03, 2014 | Option Exercise | $49.80 | 680 | 33,864 | 49,856 | May 05, 2014, 05:05 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | May 01, 2014 | Option Exercise | $49.52 | 2,593 | 128,405 | 40,002 | May 02, 2014, 04:18 PM |
JUDGE ANN POWELL | SVP, Human Resources | Apr 01, 2014 | Option Exercise | $51.87 | 473 | 24,535 | 3,220 | Apr 03, 2014, 04:17 PM |
CORNELIUS JAMES M | Director | Mar 31, 2014 | Option Exercise | $51.95 | 481 | 24,988 | 268,038 | Apr 02, 2014, 07:51 AM |
Caldarella Joseph C | SVP & Controller | Mar 13, 2014 | Sale | $55.20 | 9,137 | 504,362 | 68,965 | Mar 13, 2014, 04:32 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 10, 2014 | Option Exercise | $56.14 | 2,065 | 115,929 | 57,523 | Mar 12, 2014, 04:54 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 10, 2014 | Option Exercise | $56.14 | 1,212 | 68,042 | 11,631 | Mar 12, 2014, 04:53 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 10, 2014 | Option Exercise | $56.14 | 414 | 23,242 | 43,330 | Mar 12, 2014, 04:53 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 10, 2014 | Option Exercise | $56.14 | 885 | 49,684 | 37,595 | Mar 12, 2014, 04:53 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 10, 2014 | Option Exercise | $56.14 | 3,678 | 206,483 | 260,656 | Mar 12, 2014, 04:52 PM |
JUDGE ANN POWELL | SVP, Human Resources | Mar 10, 2014 | Option Exercise | $56.14 | 924 | 51,873 | 2,139 | Mar 12, 2014, 04:52 PM |
Heller Frances K | SVP, Business Development | Mar 10, 2014 | Option Exercise | $56.14 | 958 | 53,782 | 4,174 | Mar 12, 2014, 04:52 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 10, 2014 | Option Exercise | $56.14 | 1,212 | 68,042 | 49,027 | Mar 12, 2014, 04:52 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 10, 2014 | Option Exercise | $56.14 | 1,655 | 92,912 | 91,806 | Mar 12, 2014, 04:51 PM |
Cuss Francis M | EVP & CSO | Mar 10, 2014 | Option Exercise | $56.14 | 2,065 | 115,929 | 238,446 | Mar 12, 2014, 04:51 PM |
Caldarella Joseph C | SVP & Controller | Mar 10, 2014 | Option Exercise | $56.14 | 1,506 | 84,547 | 78,102 | Mar 12, 2014, 04:51 PM |
Caforio Giovanni | EVP & Chief Commercial Officer | Mar 10, 2014 | Option Exercise | $56.14 | 3,678 | 206,483 | 67,446 | Mar 12, 2014, 04:51 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 10, 2014 | Option Exercise | $56.14 | 4,196 | 235,563 | 164,185 | Mar 12, 2014, 04:50 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 10, 2014 | Option Exercise | $56.14 | 22,451 | 1,260,399 | 648,479 | Mar 12, 2014, 04:50 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 06, 2014 | Option Exercise | $55.56 | 2,081 | 115,620 | 55,606 | Mar 10, 2014, 04:43 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 06, 2014 | Option Exercise | $55.56 | 1,281 | 71,172 | 17,660 | Mar 10, 2014, 04:43 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 10, 2014 | Sale | $55.81 | 8,799 | 491,063 | 8,861 | Mar 10, 2014, 04:43 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 06, 2014 | Option Exercise | $55.56 | 504 | 28,002 | 42,744 | Mar 10, 2014, 04:42 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 06, 2014 | Option Exercise | $55.56 | 774 | 43,003 | 36,775 | Mar 10, 2014, 04:42 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 06, 2014 | Option Exercise | $55.56 | 4,852 | 269,577 | 257,242 | Mar 10, 2014, 04:42 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 06, 2014 | Option Exercise | $55.56 | 789 | 43,837 | 47,549 | Mar 10, 2014, 04:42 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 06, 2014 | Option Exercise | $55.56 | 2,276 | 126,455 | 89,786 | Mar 10, 2014, 04:41 PM |
Cuss Francis M | EVP & CSO | Mar 06, 2014 | Option Exercise | $55.56 | 2,621 | 145,623 | 236,529 | Mar 10, 2014, 04:41 PM |
Caldarella Joseph C | SVP & Controller | Mar 06, 2014 | Option Exercise | $55.56 | 1,815 | 100,841 | 76,918 | Mar 10, 2014, 04:41 PM |
Caforio Giovanni | EVP & Chief Commercial Officer | Mar 06, 2014 | Option Exercise | $55.56 | 2,516 | 139,789 | 64,032 | Mar 10, 2014, 04:40 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 06, 2014 | Option Exercise | $55.56 | 5,536 | 307,580 | 159,062 | Mar 10, 2014, 04:40 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 06, 2014 | Option Exercise | $55.56 | 27,454 | 1,525,344 | 730,783 | Mar 10, 2014, 04:40 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 10, 2014 | Sale | $55.52 | 100,000 | 5,552,260 | 630,783 | Mar 10, 2014, 04:40 PM |
CORNELIUS JAMES M | Director | Mar 05, 2014 | Sale | $55.82 | 100,000 | 5,582,000 | 273,393 | Mar 05, 2014, 04:40 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 03, 2014 | Option Exercise | $53.49 | 20,280 | 1,084,777 | 53,674 | Mar 05, 2014, 04:40 PM |
Nielsen Anne | Chief Compliance & Ethics Off | Mar 03, 2014 | Option Exercise | $53.49 | 6,227 | 333,082 | 42,032 | Mar 05, 2014, 04:39 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 03, 2014 | Option Exercise | $53.49 | 6,589 | 352,446 | 35,798 | Mar 05, 2014, 04:39 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 03, 2014 | Option Exercise | $53.49 | 57,828 | 3,093,220 | 252,737 | Mar 05, 2014, 04:38 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 03, 2014 | Option Exercise | $53.49 | 6,361 | 340,250 | 46,587 | Mar 05, 2014, 04:37 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 03, 2014 | Option Exercise | $53.49 | 24,383 | 1,304,247 | 87,008 | Mar 05, 2014, 04:37 PM |
Cuss Francis M | EVP & CSO | Mar 03, 2014 | Option Exercise | $53.49 | 28,928 | 1,547,359 | 234,096 | Mar 05, 2014, 04:36 PM |
Caldarella Joseph C | SVP & Controller | Mar 03, 2014 | Option Exercise | $53.49 | 19,160 | 1,024,868 | 75,491 | Mar 05, 2014, 04:36 PM |
Caforio Giovanni | EVP & Chief Commercial Officer | Mar 03, 2014 | Option Exercise | $53.49 | 9,622 | 514,681 | 61,697 | Mar 05, 2014, 04:36 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 03, 2014 | Option Exercise | $53.49 | 61,419 | 3,285,302 | 152,303 | Mar 05, 2014, 04:35 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 03, 2014 | Option Exercise | $53.49 | 61,582 | 3,294,021 | 549,009 | Mar 05, 2014, 04:35 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Feb 28, 2014 | Sale | $54.49 | 6,088 | 331,736 | 14,696 | Feb 28, 2014, 04:44 PM |
Caforio Giovanni | EVP & Chief Commercial Officer | Feb 24, 2014 | Option Exercise | $17.51 | 39,363 | 689,246 | 91,316 | Feb 25, 2014, 04:30 PM |
Caforio Giovanni | EVP & Chief Commercial Officer | Feb 24, 2014 | Sale | $54.44 | 41,563 | 2,262,638 | 64,701 | Feb 25, 2014, 04:30 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Feb 19, 2014 | Sale | $54.22 | 9,534 | 516,911 | 36,573 | Feb 19, 2014, 04:25 PM |
Cuss Francis M | EVP & CSO | Feb 18, 2014 | Option Exercise | $28.11 | 38,667 | 1,086,929 | 237,037 | Feb 18, 2014, 05:07 PM |
Cuss Francis M | EVP & CSO | Feb 18, 2014 | Sale | $54.61 | 29,800 | 1,627,360 | 207,237 | Feb 18, 2014, 05:07 PM |
LEUNG SANDRA | General Counsel & Secretary | Feb 14, 2014 | Option Exercise | $28.11 | 15,000 | 421,650 | 206,345 | Feb 18, 2014, 05:07 PM |
LEUNG SANDRA | General Counsel & Secretary | Feb 14, 2014 | Sale | $54.28 | 10,490 | 569,377 | 195,855 | Feb 18, 2014, 05:07 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Feb 14, 2014 | Option Exercise | $24.00 | 36,251 | 870,038 | 130,266 | Feb 18, 2014, 05:07 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Feb 14, 2014 | Sale | $54.35 | 52,963 | 2,878,285 | 77,303 | Feb 18, 2014, 05:07 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Feb 11, 2014 | Option Exercise | $28.11 | 108,000 | 3,035,880 | 586,562 | Feb 11, 2014, 04:30 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Feb 11, 2014 | Sale | $52.66 | 86,075 | 4,532,572 | 500,487 | Feb 11, 2014, 04:30 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Feb 06, 2014 | Option Exercise | $28.11 | 18,750 | 527,063 | 81,989 | Feb 06, 2014, 05:29 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Feb 06, 2014 | Sale | $48.93 | 28,440 | 1,391,433 | 53,549 | Feb 06, 2014, 05:29 PM |
Caldarella Joseph C | SVP & Controller | Feb 06, 2014 | Option Exercise | $19.42 | 26,484 | 514,202 | 94,826 | Feb 06, 2014, 05:28 PM |
Caldarella Joseph C | SVP & Controller | Feb 06, 2014 | Sale | $48.90 | 35,471 | 1,734,457 | 59,355 | Feb 06, 2014, 05:28 PM |
CAMPBELL LEWIS B | Director | Feb 05, 2014 | Option Exercise | $25.70 | 2,500 | 64,250 | 2,500 | Feb 05, 2014, 05:37 PM |
CAMPBELL LEWIS B | Director | Feb 05, 2014 | Sale | $48.28 | 2,500 | 120,712 | 100 | Feb 05, 2014, 05:37 PM |
CORNELIUS JAMES M | Director | Feb 04, 2014 | Sale | $48.90 | 100,000 | 4,890,000 | 373,393 | Feb 04, 2014, 05:00 PM |
Caforio Giovanni | EVP & Chief Commercial Officer | Jan 03, 2014 | Option Exercise | $52.85 | 2,864 | 151,362 | 51,953 | Jan 06, 2014, 05:40 PM |
CORNELIUS JAMES M | Director | Dec 31, 2013 | Option Exercise | $53.15 | 470 | 24,981 | 473,393 | Jan 02, 2014, 04:09 PM |
Cuss Francis M | EVP & CSO | Nov 02, 2013 | Option Exercise | $52.48 | 3,457 | 181,423 | 198,370 | Nov 04, 2013, 04:20 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Oct 03, 2013 | Option Exercise | $46.56 | 5,085 | 236,758 | 20,784 | Oct 04, 2013, 04:19 PM |
Heller Frances K | SVP, Business Development | Oct 01, 2013 | Option Exercise | $47.24 | 1,658 | 78,324 | 2,793 | Oct 02, 2013, 04:23 PM |
CORNELIUS JAMES M | Director | Jul 29, 2013 | Sale | $43.92 | 100,000 | 4,392,000 | 542,383 | Jul 30, 2013, 04:34 PM |
CORNELIUS JAMES M | Director | Jul 29, 2013 | Option Exercise | $25.60 | 5,000 | 128,025 | 647,383 | Jul 29, 2013, 04:44 PM |
CORNELIUS JAMES M | Director | Jul 29, 2013 | Sale | $43.81 | 5,000 | 219,050 | 642,383 | Jul 29, 2013, 04:44 PM |
CORNELIUS JAMES M | Director | Jun 30, 2013 | Option Exercise | $44.69 | 559 | 24,982 | 642,383 | Jul 02, 2013, 04:21 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Jun 10, 2013 | Sale | $47.24 | 25,000 | 1,181,000 | 29,584 | Jun 12, 2013, 04:34 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Jun 04, 2013 | Sale | $47.74 | 100,000 | 4,774,000 | 478,562 | Jun 06, 2013, 04:31 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Jun 04, 2013 | Option Exercise | $25.70 | 60,100 | 1,544,273 | 83,585 | Jun 06, 2013, 04:31 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Jun 04, 2013 | Sale | $47.38 | 58,898 | 2,790,587 | 24,687 | Jun 06, 2013, 04:31 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Jun 05, 2013 | Option Exercise | $20.39 | 33,715 | 687,348 | 68,271 | Jun 06, 2013, 04:31 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Jun 05, 2013 | Sale | $46.33 | 25,997 | 1,204,441 | 42,274 | Jun 06, 2013, 04:31 PM |
Caldarella Joseph C | SVP & Controller | Jun 06, 2013 | Option Exercise | $22.14 | 25,000 | 553,500 | 94,617 | Jun 06, 2013, 04:31 PM |
Caldarella Joseph C | SVP & Controller | Jun 06, 2013 | Sale | $46.53 | 26,275 | 1,222,576 | 68,342 | Jun 06, 2013, 04:31 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Jun 03, 2013 | Option Exercise | $27.01 | 98,875 | 2,670,614 | 231,868 | Jun 05, 2013, 04:28 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Jun 03, 2013 | Sale | $48.18 | 83,647 | 4,030,112 | 148,221 | Jun 05, 2013, 04:28 PM |
Cazala Beatrice J | EVP Commercial Operations | May 31, 2013 | Sale | $47.00 | 91,282 | 4,290,254 | 173,375 | Jun 04, 2013, 04:18 PM |
Cazala Beatrice J | EVP Commercial Operations | May 30, 2013 | Sale | $47.00 | 22,000 | 1,034,000 | 264,657 | Jun 03, 2013, 05:56 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | May 31, 2013 | Sale | $47.06 | 10,538 | 495,918 | 47,316 | May 31, 2013, 06:14 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | May 30, 2013 | Option Exercise | $26.34 | 170,625 | 4,495,081 | 276,514 | May 31, 2013, 06:14 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | May 30, 2013 | Sale | $47.23 | 143,521 | 6,778,497 | 132,993 | May 31, 2013, 06:14 PM |
CORNELIUS JAMES M | Director | May 28, 2013 | Sale | $47.61 | 100,000 | 4,761,000 | 641,824 | May 28, 2013, 04:43 PM |
Bancroft Charles A | EVP & Chief Financial Officer | May 28, 2013 | Sale | $48.68 | 25,000 | 1,217,000 | 94,015 | May 28, 2013, 04:37 PM |
Cazala Beatrice J | EVP Commercial Operations | May 23, 2013 | Option Exercise | $23.90 | 116,412 | 2,782,247 | 382,657 | May 23, 2013, 05:20 PM |
Cazala Beatrice J | EVP Commercial Operations | May 23, 2013 | Sale | $46.99 | 96,000 | 4,511,040 | 286,657 | May 23, 2013, 05:20 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | May 23, 2013 | Option Exercise | $25.45 | 21,333 | 542,925 | 84,501 | May 23, 2013, 05:19 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | May 23, 2013 | Sale | $46.29 | 26,647 | 1,233,490 | 57,854 | May 23, 2013, 05:19 PM |
CORNELIUS JAMES M | Director | May 17, 2013 | Option Exercise | $22.14 | 205,996 | 4,560,751 | 957,820 | May 20, 2013, 04:17 PM |
CORNELIUS JAMES M | Director | May 17, 2013 | Sale | $42.98 | 215,996 | 9,283,708 | 947,820 | May 20, 2013, 04:17 PM |
CORNELIUS JAMES M | Director | May 16, 2013 | Sale | $43.24 | 10,000 | 432,400 | 751,824 | May 20, 2013, 04:17 PM |
CORNELIUS JAMES M | Director | May 08, 2013 | Sale | $39.78 | 10,000 | 397,800 | 761,824 | May 09, 2013, 04:19 PM |
CORNELIUS JAMES M | Director | May 07, 2013 | Sale | $39.91 | 10,000 | 399,100 | 771,824 | May 09, 2013, 04:19 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | May 08, 2013 | Sale | $39.93 | 15,000 | 598,950 | 63,239 | May 08, 2013, 04:25 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | May 04, 2013 | Option Exercise | $40.20 | 12,754 | 512,711 | 578,562 | May 07, 2013, 06:29 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | May 03, 2013 | Option Exercise | $40.20 | 679 | 27,296 | 34,556 | May 06, 2013, 05:45 PM |
CORNELIUS JAMES M | Director | May 02, 2013 | Sale | $39.85 | 10,000 | 398,500 | 781,824 | May 02, 2013, 05:01 PM |
CORNELIUS JAMES M | Director | May 01, 2013 | Sale | $39.66 | 10,000 | 396,600 | 791,824 | May 02, 2013, 05:01 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | May 01, 2013 | Option Exercise | $39.72 | 2,269 | 90,125 | 23,485 | May 02, 2013, 04:23 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 30, 2013 | Option Exercise | $24.98 | 305,905 | 7,641,575 | 459,398 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 29, 2013 | Option Exercise | $24.03 | 73,390 | 1,763,821 | 258,411 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 29, 2013 | Sale | $39.97 | 9,157 | 366,005 | 9,550 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 29, 2013 | Sale | $39.92 | 104,918 | 4,188,026 | 248,811 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 30, 2013 | Sale | $39.65 | 919 | 36,438 | 18,180 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 29, 2013 | Sale | $39.97 | 18,313 | 731,971 | 19,099 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 30, 2013 | Sale | $39.65 | 919 | 36,438 | 18,180 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 29, 2013 | Sale | $39.97 | 18,313 | 731,971 | 19,099 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 30, 2013 | Sale | $39.61 | 353,509 | 14,004,254 | 371,266 | May 01, 2013, 05:58 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Apr 30, 2013 | Sale | $39.65 | 459 | 18,199 | 9,091 | May 01, 2013, 05:58 PM |
CORNELIUS JAMES M | Director | Apr 26, 2013 | Sale | $40.12 | 10,000 | 401,200 | 801,824 | Apr 29, 2013, 04:22 PM |
CORNELIUS JAMES M | Director | Apr 25, 2013 | Sale | $40.34 | 10,000 | 403,400 | 811,824 | Apr 29, 2013, 04:22 PM |
CORNELIUS JAMES M | Director | Apr 17, 2013 | Sale | $40.75 | 10,000 | 407,500 | 821,824 | Apr 18, 2013, 04:18 PM |
CORNELIUS JAMES M | Director | Apr 16, 2013 | Sale | $40.82 | 10,000 | 408,200 | 831,824 | Apr 18, 2013, 04:18 PM |
CORNELIUS JAMES M | Director | Apr 11, 2013 | Sale | $41.31 | 10,000 | 413,100 | 841,824 | Apr 11, 2013, 05:13 PM |
CORNELIUS JAMES M | Director | Apr 10, 2013 | Sale | $40.99 | 10,000 | 409,900 | 851,824 | Apr 11, 2013, 05:13 PM |
CORNELIUS JAMES M | Director | Mar 31, 2013 | Option Exercise | $41.19 | 606 | 24,961 | 881,824 | Apr 02, 2013, 05:03 PM |
CORNELIUS JAMES M | Director | Apr 02, 2013 | Sale | $41.59 | 10,000 | 415,900 | 861,824 | Apr 02, 2013, 05:03 PM |
CORNELIUS JAMES M | Director | Apr 01, 2013 | Sale | $41.09 | 10,000 | 410,900 | 871,824 | Apr 02, 2013, 05:03 PM |
CORNELIUS JAMES M | Director | Mar 26, 2013 | Sale | $40.62 | 10,000 | 406,200 | 891,218 | Mar 28, 2013, 04:31 PM |
CORNELIUS JAMES M | Director | Mar 27, 2013 | Sale | $40.68 | 10,000 | 406,800 | 881,218 | Mar 28, 2013, 04:31 PM |
CORNELIUS JAMES M | Director | Mar 21, 2013 | Sale | $39.78 | 10,000 | 397,800 | 901,218 | Mar 22, 2013, 04:16 PM |
CORNELIUS JAMES M | Director | Mar 20, 2013 | Sale | $39.78 | 10,000 | 397,800 | 911,218 | Mar 22, 2013, 04:16 PM |
Cuss Francis M | SVP Research | Mar 13, 2013 | Option Exercise | $23.80 | 84,952 | 2,021,809 | 264,874 | Mar 14, 2013, 04:26 PM |
Cuss Francis M | SVP Research | Mar 13, 2013 | Sale | $38.47 | 69,713 | 2,681,859 | 195,161 | Mar 14, 2013, 04:26 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 13, 2013 | Sale | $38.51 | 3,409 | 131,281 | 33,727 | Mar 14, 2013, 04:26 PM |
CORNELIUS JAMES M | Director | Mar 13, 2013 | Sale | $38.34 | 10,000 | 383,400 | 921,218 | Mar 14, 2013, 04:26 PM |
CORNELIUS JAMES M | Director | Mar 12, 2013 | Sale | $38.02 | 10,000 | 380,200 | 931,218 | Mar 14, 2013, 04:26 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 07, 2013 | Option Exercise | $37.53 | 11,639 | 436,812 | 65,238 | Mar 11, 2013, 04:50 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 07, 2013 | Option Exercise | $37.53 | 5,865 | 220,113 | 26,176 | Mar 11, 2013, 04:50 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 07, 2013 | Option Exercise | $37.53 | 5,051 | 189,564 | 41,825 | Mar 11, 2013, 04:50 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 07, 2013 | Option Exercise | $37.53 | 75,039 | 2,816,214 | 254,866 | Mar 11, 2013, 04:50 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Mar 07, 2013 | Option Exercise | $37.53 | 6,972 | 261,659 | 69,474 | Mar 11, 2013, 04:47 PM |
Cazala Beatrice J | EVP Commercial Operations | Mar 07, 2013 | Option Exercise | $37.53 | 45,722 | 1,715,947 | 391,395 | Mar 11, 2013, 04:47 PM |
Cazala Beatrice J | EVP Commercial Operations | Mar 07, 2013 | Option Exercise | $24.74 | 100,000 | 2,474,000 | 307,543 | Mar 11, 2013, 04:47 PM |
Cazala Beatrice J | EVP Commercial Operations | Mar 07, 2013 | Sale | $37.61 | 83,750 | 3,149,838 | 266,245 | Mar 11, 2013, 04:47 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 07, 2013 | Option Exercise | $37.53 | 44,508 | 1,670,385 | 232,564 | Mar 11, 2013, 04:44 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 07, 2013 | Option Exercise | $37.53 | 20,632 | 774,319 | 97,595 | Mar 11, 2013, 04:43 PM |
Cuss Francis M | SVP Research | Mar 07, 2013 | Option Exercise | $37.53 | 22,139 | 830,877 | 200,785 | Mar 11, 2013, 04:40 PM |
Caldarella Joseph C | SVP & Controller | Mar 07, 2013 | Option Exercise | $37.53 | 11,197 | 420,223 | 79,905 | Mar 11, 2013, 04:40 PM |
Schmukler Louis S | Pres., Global Mfg. & Supply | Mar 07, 2013 | Option Exercise | $37.53 | 859 | 32,238 | 11,935 | Mar 11, 2013, 04:37 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 07, 2013 | Option Exercise | $37.53 | 31,429 | 1,179,530 | 147,873 | Mar 11, 2013, 04:37 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 07, 2013 | Option Exercise | $37.53 | 198,015 | 7,431,503 | 752,850 | Mar 11, 2013, 04:33 PM |
CORNELIUS JAMES M | Director | Mar 07, 2013 | Sale | $37.67 | 10,000 | 376,700 | 951,218 | Mar 11, 2013, 04:28 PM |
CORNELIUS JAMES M | Director | Mar 08, 2013 | Sale | $37.41 | 10,000 | 374,100 | 941,218 | Mar 11, 2013, 04:28 PM |
Cazala Beatrice J | EVP Commercial Operations | Mar 06, 2013 | Option Exercise | $37.76 | 1,333 | 50,334 | 207,543 | Mar 07, 2013, 04:05 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 04, 2013 | Option Exercise | $36.94 | 3,865 | 142,773 | 115,341 | Mar 05, 2013, 04:55 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 03, 2013 | Option Exercise | $37.15 | 24,041 | 893,123 | 111,753 | Mar 05, 2013, 04:55 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 04, 2013 | Option Exercise | $36.94 | 1,483 | 54,782 | 146,982 | Mar 05, 2013, 04:54 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 03, 2013 | Option Exercise | $37.15 | 1,786 | 66,350 | 144,485 | Mar 05, 2013, 04:54 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 04, 2013 | Option Exercise | $36.94 | 697 | 25,747 | 52,872 | Mar 05, 2013, 04:54 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 03, 2013 | Option Exercise | $37.15 | 1,002 | 37,224 | 51,699 | Mar 05, 2013, 04:54 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 03, 2013 | Option Exercise | $37.15 | 4,264 | 158,408 | 405,071 | Mar 05, 2013, 04:54 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 04, 2013 | Option Exercise | $36.94 | 3,073 | 113,517 | 409,451 | Mar 05, 2013, 04:54 PM |
von Autenried Paul | SVP, Enterp. Services & CIO | Mar 03, 2013 | Option Exercise | $37.15 | 903 | 33,546 | 41,644 | Mar 05, 2013, 04:27 PM |
Moed Samuel J | SVP, Strat Plan & Analysis | Mar 03, 2013 | Option Exercise | $37.15 | 711 | 26,414 | 10,883 | Mar 05, 2013, 04:27 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Mar 03, 2013 | Option Exercise | $37.15 | 564 | 20,953 | 25,595 | Mar 05, 2013, 04:27 PM |
Cuss Francis M | SVP Research | Mar 03, 2013 | Option Exercise | $37.15 | 1,393 | 51,750 | 152,958 | Mar 05, 2013, 04:26 PM |
Caldarella Joseph C | SVP & Controller | Mar 03, 2013 | Option Exercise | $37.15 | 985 | 36,593 | 57,776 | Mar 05, 2013, 04:26 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Mar 03, 2013 | Option Exercise | $37.15 | 690 | 25,634 | 53,011 | Mar 05, 2013, 04:26 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 03, 2013 | Option Exercise | $37.15 | 757 | 28,123 | 72,806 | Mar 05, 2013, 04:24 PM |
CORNELIUS JAMES M | Director | Feb 26, 2013 | Sale | $36.44 | 10,000 | 364,400 | 1,061,218 | Feb 27, 2013, 04:08 PM |
CORNELIUS JAMES M | Director | Feb 25, 2013 | Sale | $36.71 | 10,000 | 367,100 | 1,071,218 | Feb 27, 2013, 04:08 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Feb 27, 2013 | Sale | $37.08 | 12,150 | 450,522 | 51,850 | Feb 27, 2013, 04:08 PM |
CORNELIUS JAMES M | Director | Feb 21, 2013 | Sale | $36.67 | 10,000 | 366,700 | 1,081,218 | Feb 21, 2013, 06:06 PM |
CORNELIUS JAMES M | Director | Feb 20, 2013 | Sale | $36.87 | 10,000 | 368,700 | 1,091,218 | Feb 21, 2013, 06:06 PM |
Caldarella Joseph C | SVP & Controller | Feb 20, 2013 | Option Exercise | $25.13 | 40,308 | 1,012,920 | 93,967 | Feb 20, 2013, 04:12 PM |
Caldarella Joseph C | SVP & Controller | Feb 20, 2013 | Sale | $36.87 | 37,585 | 1,385,759 | 56,382 | Feb 20, 2013, 04:12 PM |
CORNELIUS JAMES M | Director | Feb 13, 2013 | Sale | $36.15 | 10,000 | 361,500 | 1,101,218 | Feb 13, 2013, 05:09 PM |
CORNELIUS JAMES M | Director | Feb 12, 2013 | Sale | $36.68 | 10,000 | 366,800 | 1,111,218 | Feb 13, 2013, 05:09 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Feb 11, 2013 | Option Exercise | $28.11 | 16,875 | 474,356 | 39,572 | Feb 11, 2013, 04:08 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Feb 11, 2013 | Sale | $36.97 | 15,264 | 564,359 | 34,672 | Feb 11, 2013, 04:08 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Feb 08, 2013 | Option Exercise | $20.81 | 266,082 | 5,536,826 | 314,134 | Feb 11, 2013, 04:08 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Feb 08, 2013 | Sale | $36.79 | 224,705 | 8,266,897 | 89,429 | Feb 11, 2013, 04:08 PM |
CORNELIUS JAMES M | Director | Feb 07, 2013 | Sale | $36.42 | 10,000 | 364,200 | 1,121,218 | Feb 08, 2013, 04:30 PM |
CORNELIUS JAMES M | Director | Feb 06, 2013 | Sale | $36.51 | 10,000 | 365,100 | 1,131,218 | Feb 08, 2013, 04:30 PM |
LEUNG SANDRA | General Counsel & Secretary | Feb 05, 2013 | Option Exercise | $23.14 | 19,310 | 446,833 | 158,258 | Feb 05, 2013, 04:18 PM |
von Autenried Paul | SVP & CIO | Feb 04, 2013 | Option Exercise | $25.57 | 56,212 | 1,437,227 | 90,425 | Feb 05, 2013, 04:18 PM |
LEUNG SANDRA | General Counsel & Secretary | Feb 05, 2013 | Sale | $36.87 | 16,780 | 618,679 | 141,478 | Feb 05, 2013, 04:18 PM |
von Autenried Paul | SVP & CIO | Feb 04, 2013 | Sale | $36.67 | 50,300 | 1,844,501 | 40,125 | Feb 05, 2013, 04:18 PM |
CAMPBELL LEWIS B | Director | Feb 04, 2013 | Option Exercise | $25.51 | 3,500 | 89,285 | 3,500 | Feb 05, 2013, 04:06 PM |
CAMPBELL LEWIS B | Director | Feb 04, 2013 | Sale | $36.77 | 3,500 | 128,695 | 0 | Feb 05, 2013, 04:06 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Jan 31, 2013 | Sale | $36.22 | 12,000 | 434,640 | 50,010 | Jan 31, 2013, 04:54 PM |
GLIMCHER LAURIE H M.D. | Director | Jan 30, 2013 | Option Exercise | $25.60 | 11,000 | 281,560 | 11,000 | Jan 30, 2013, 04:16 PM |
GLIMCHER LAURIE H M.D. | Director | Jan 30, 2013 | Sale | $36.40 | 11,000 | 400,400 | 0 | Jan 30, 2013, 04:16 PM |
CORNELIUS JAMES M | Director | Jan 28, 2013 | Sale | $36.43 | 10,000 | 364,300 | 1,151,218 | Jan 30, 2013, 04:06 PM |
CORNELIUS JAMES M | Director | Jan 29, 2013 | Sale | $36.53 | 10,000 | 365,300 | 1,141,218 | Jan 30, 2013, 04:06 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Jan 28, 2013 | Option Exercise | $28.67 | 22,500 | 645,075 | 84,350 | Jan 28, 2013, 04:32 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Jan 28, 2013 | Sale | $36.19 | 20,350 | 736,466 | 64,000 | Jan 28, 2013, 04:32 PM |
CORNELIUS JAMES M | Director | Jan 25, 2013 | Sale | $36.32 | 10,000 | 363,200 | 1,161,218 | Jan 28, 2013, 04:11 PM |
CORNELIUS JAMES M | Director | Jan 24, 2013 | Sale | $35.78 | 10,000 | 357,811 | 1,181,118 | Jan 28, 2013, 04:11 PM |
CORNELIUS JAMES M | Director | Jan 17, 2013 | Sale | $34.33 | 10,000 | 343,300 | 1,181,218 | Jan 18, 2013, 04:40 PM |
CORNELIUS JAMES M | Director | Jan 16, 2013 | Sale | $34.33 | 10,000 | 343,300 | 1,191,218 | Jan 18, 2013, 04:40 PM |
CORNELIUS JAMES M | Director | Jan 08, 2013 | Sale | $33.58 | 10,000 | 335,800 | 1,201,218 | Jan 09, 2013, 04:15 PM |
CORNELIUS JAMES M | Director | Jan 07, 2013 | Sale | $33.40 | 10,000 | 334,000 | 1,211,218 | Jan 09, 2013, 04:15 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Jan 03, 2013 | Option Exercise | $33.24 | 2,910 | 96,728 | 61,850 | Jan 07, 2013, 04:25 PM |
CORNELIUS JAMES M | Director | Jan 04, 2013 | Sale | $33.26 | 10,000 | 332,600 | 1,221,218 | Jan 07, 2013, 04:25 PM |
CORNELIUS JAMES M | Director | Jan 03, 2013 | Sale | $32.98 | 10,000 | 329,800 | 1,231,218 | Jan 07, 2013, 04:25 PM |
CORNELIUS JAMES M | Director | Dec 31, 2012 | Option Exercise | $32.59 | 767 | 24,997 | 1,241,218 | Jan 02, 2013, 04:10 PM |
CORNELIUS JAMES M | Director | Dec 28, 2012 | Sale | $32.09 | 10,000 | 320,900 | 1,240,451 | Dec 28, 2012, 05:59 PM |
CORNELIUS JAMES M | Director | Dec 27, 2012 | Sale | $32.02 | 10,000 | 320,200 | 1,250,451 | Dec 28, 2012, 05:59 PM |
CORNELIUS JAMES M | Director | Dec 21, 2012 | Sale | $32.48 | 10,000 | 324,800 | 1,260,451 | Dec 21, 2012, 05:56 PM |
CORNELIUS JAMES M | Director | Dec 20, 2012 | Sale | $32.52 | 10,000 | 325,200 | 1,270,451 | Dec 21, 2012, 05:56 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Dec 17, 2012 | Option Exercise | $25.28 | 47,125 | 1,191,115 | 113,920 | Dec 18, 2012, 04:15 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Dec 17, 2012 | Sale | $32.77 | 42,844 | 1,403,998 | 71,076 | Dec 18, 2012, 04:15 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Dec 11, 2012 | Sale | $33.00 | 62,903 | 2,075,799 | 37,412 | Dec 13, 2012, 04:28 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Dec 11, 2012 | Sale | $33.00 | 62,903 | 2,075,799 | 37,412 | Dec 13, 2012, 04:28 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Dec 11, 2012 | Sale | $33.00 | 31,451 | 1,037,883 | 18,707 | Dec 13, 2012, 04:28 PM |
CORNELIUS JAMES M | Director | Dec 12, 2012 | Option Exercise | $22.14 | 400,000 | 8,856,000 | 1,290,451 | Dec 13, 2012, 04:20 PM |
CORNELIUS JAMES M | Director | Dec 12, 2012 | Sale | $33.31 | 10,000 | 333,100 | 1,280,451 | Dec 13, 2012, 04:20 PM |
CORNELIUS JAMES M | Director | Dec 11, 2012 | Sale | $33.10 | 10,000 | 331,000 | 890,451 | Dec 13, 2012, 04:20 PM |
CORNELIUS JAMES M | Director | Dec 03, 2012 | Sale | $32.68 | 10,000 | 326,800 | 910,451 | Dec 04, 2012, 05:08 PM |
CORNELIUS JAMES M | Director | Dec 04, 2012 | Sale | $32.64 | 10,000 | 326,400 | 900,451 | Dec 04, 2012, 05:08 PM |
CORNELIUS JAMES M | Director | Nov 28, 2012 | Sale | $32.58 | 10,000 | 325,800 | 920,451 | Nov 29, 2012, 04:08 PM |
CORNELIUS JAMES M | Director | Nov 27, 2012 | Sale | $32.69 | 10,000 | 326,900 | 930,451 | Nov 29, 2012, 04:08 PM |
CORNELIUS JAMES M | Director | Nov 20, 2012 | Sale | $32.04 | 10,000 | 320,400 | 940,451 | Nov 20, 2012, 04:48 PM |
CORNELIUS JAMES M | Director | Nov 19, 2012 | Sale | $31.90 | 10,000 | 319,000 | 950,451 | Nov 20, 2012, 04:48 PM |
CORNELIUS JAMES M | Director | Nov 13, 2012 | Sale | $32.04 | 10,000 | 320,400 | 970,451 | Nov 15, 2012, 04:18 PM |
CORNELIUS JAMES M | Director | Nov 14, 2012 | Sale | $31.65 | 10,000 | 316,500 | 960,451 | Nov 15, 2012, 04:18 PM |
CORNELIUS JAMES M | Director | Nov 06, 2012 | Sale | $33.27 | 10,000 | 332,700 | 980,451 | Nov 06, 2012, 05:15 PM |
CORNELIUS JAMES M | Director | Nov 05, 2012 | Sale | $33.11 | 10,000 | 331,100 | 990,451 | Nov 06, 2012, 05:15 PM |
Cuss Francis M | SVP Research | Nov 02, 2012 | Option Exercise | $33.18 | 3,091 | 102,559 | 150,599 | Nov 05, 2012, 04:13 PM |
Elicker John E | SVP Pub Affairs & Inv Relation | Oct 26, 2012 | Sale | $33.55 | 2,214 | 74,280 | 22,697 | Oct 29, 2012, 05:03 PM |
CORNELIUS JAMES M | Director | Oct 23, 2012 | Sale | $33.26 | 10,000 | 332,600 | 1,000,451 | Oct 24, 2012, 04:18 PM |
CORNELIUS JAMES M | Director | Oct 22, 2012 | Sale | $33.81 | 10,000 | 338,100 | 1,010,451 | Oct 24, 2012, 04:18 PM |
CORNELIUS JAMES M | Director | Oct 17, 2012 | Sale | $34.34 | 10,000 | 343,400 | 1,020,451 | Oct 18, 2012, 04:18 PM |
CORNELIUS JAMES M | Director | Oct 16, 2012 | Sale | $34.15 | 10,000 | 341,500 | 1,030,451 | Oct 18, 2012, 04:18 PM |
CORNELIUS JAMES M | Director | Oct 12, 2012 | Sale | $33.08 | 10,000 | 330,800 | 1,040,451 | Oct 15, 2012, 04:27 PM |
CORNELIUS JAMES M | Director | Oct 11, 2012 | Sale | $33.06 | 10,000 | 330,600 | 1,050,451 | Oct 15, 2012, 04:27 PM |
Schmukler Louis S | Pres., Global Manufacturing & | Oct 03, 2012 | Option Exercise | $33.56 | 4,114 | 138,066 | 9,819 | Oct 04, 2012, 04:07 PM |
CORNELIUS JAMES M | Director | Oct 02, 2012 | Sale | $33.88 | 10,000 | 338,800 | 1,070,451 | Oct 04, 2012, 04:06 PM |
CORNELIUS JAMES M | Director | Oct 03, 2012 | Sale | $33.53 | 10,000 | 335,300 | 1,060,451 | Oct 04, 2012, 04:06 PM |
CORNELIUS JAMES M | Director | Sep 30, 2012 | Option Exercise | $33.75 | 740 | 24,975 | 1,080,451 | Oct 01, 2012, 04:06 PM |
CORNELIUS JAMES M | Director | Sep 28, 2012 | Sale | $33.75 | 10,000 | 337,500 | 1,079,711 | Oct 01, 2012, 04:06 PM |
CORNELIUS JAMES M | Director | Sep 27, 2012 | Sale | $33.88 | 10,000 | 338,800 | 1,089,711 | Oct 01, 2012, 04:06 PM |
CORNELIUS JAMES M | Director | Sep 19, 2012 | Sale | $32.97 | 10,000 | 329,700 | 1,099,711 | Sep 20, 2012, 04:11 PM |
CORNELIUS JAMES M | Director | Sep 18, 2012 | Sale | $32.98 | 10,000 | 329,800 | 1,109,711 | Sep 20, 2012, 04:11 PM |
Caldarella Joseph C | SVP & Controller | Sep 07, 2012 | Option Exercise | $28.11 | 16,500 | 463,815 | 75,814 | Sep 07, 2012, 04:11 PM |
Caldarella Joseph C | SVP & Controller | Sep 07, 2012 | Sale | $33.16 | 22,155 | 734,660 | 69,074 | Sep 07, 2012, 04:11 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Sep 05, 2012 | Option Exercise | $23.14 | 135,000 | 3,123,900 | 514,491 | Sep 07, 2012, 04:08 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Sep 05, 2012 | Sale | $33.05 | 115,500 | 3,817,275 | 398,991 | Sep 07, 2012, 04:08 PM |
Cuss Francis M | SVP Research | Aug 30, 2012 | Option Exercise | $20.39 | 147,618 | 3,010,191 | 265,212 | Sep 04, 2012, 04:12 PM |
Cuss Francis M | SVP Research | Aug 30, 2012 | Sale | $32.89 | 118,190 | 3,887,269 | 147,022 | Sep 04, 2012, 04:12 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Aug 24, 2012 | Option Exercise | $23.18 | 30,458 | 705,925 | 83,160 | Aug 28, 2012, 04:07 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Aug 24, 2012 | Sale | $32.69 | 25,900 | 846,671 | 57,260 | Aug 28, 2012, 04:07 PM |
CORNELIUS JAMES M | Director | Aug 14, 2012 | Option Exercise | $22.14 | 400,000 | 8,856,000 | 1,274,711 | Aug 15, 2012, 04:09 PM |
CORNELIUS JAMES M | Director | Aug 14, 2012 | Sale | $31.60 | 5,000 | 158,000 | 1,269,711 | Aug 15, 2012, 04:09 PM |
CORNELIUS JAMES M | Director | Aug 13, 2012 | Sale | $31.56 | 5,000 | 157,800 | 874,711 | Aug 15, 2012, 04:09 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Aug 10, 2012 | Option Exercise | $17.94 | 77,545 | 1,391,531 | 141,910 | Aug 14, 2012, 04:18 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Aug 10, 2012 | Sale | $31.72 | 79,900 | 2,534,428 | 62,010 | Aug 14, 2012, 04:18 PM |
Cazala Beatrice J | EVP Commercial Operations | Aug 10, 2012 | Option Exercise | $25.07 | 156,662 | 3,926,808 | 348,881 | Aug 14, 2012, 04:14 PM |
Cazala Beatrice J | EVP Commercial Operations | Aug 10, 2012 | Sale | $31.79 | 143,600 | 4,565,044 | 205,281 | Aug 14, 2012, 04:14 PM |
CORNELIUS JAMES M | Director | Aug 10, 2012 | Sale | $31.76 | 5,000 | 158,800 | 879,711 | Aug 13, 2012, 04:42 PM |
CORNELIUS JAMES M | Director | Aug 09, 2012 | Sale | $31.85 | 5,000 | 159,250 | 884,711 | Aug 13, 2012, 04:42 PM |
CORNELIUS JAMES M | Director | Aug 01, 2012 | Sale | $35.84 | 5,000 | 179,200 | 894,711 | Aug 02, 2012, 06:30 PM |
CORNELIUS JAMES M | Director | Aug 02, 2012 | Sale | $32.81 | 5,000 | 164,050 | 889,711 | Aug 02, 2012, 06:30 PM |
CORNELIUS JAMES M | Director | Jul 26, 2012 | Sale | $35.74 | 5,000 | 178,700 | 899,711 | Jul 26, 2012, 04:48 PM |
CORNELIUS JAMES M | Director | Jul 25, 2012 | Sale | $34.84 | 5,000 | 174,200 | 904,711 | Jul 26, 2012, 04:48 PM |
CORNELIUS JAMES M | Director | Jul 19, 2012 | Sale | $36.07 | 5,000 | 180,350 | 909,711 | Jul 20, 2012, 04:11 PM |
CORNELIUS JAMES M | Director | Jul 18, 2012 | Sale | $36.04 | 5,000 | 180,200 | 914,711 | Jul 20, 2012, 04:11 PM |
CORNELIUS JAMES M | Director | Jul 12, 2012 | Sale | $34.85 | 5,000 | 174,250 | 924,711 | Jul 16, 2012, 04:14 PM |
CORNELIUS JAMES M | Director | Jul 13, 2012 | Sale | $35.35 | 5,000 | 176,750 | 919,711 | Jul 16, 2012, 04:14 PM |
CORNELIUS JAMES M | Director | Jun 30, 2012 | Option Exercise | $35.95 | 695 | 24,985 | 939,711 | Jul 03, 2012, 02:23 PM |
CORNELIUS JAMES M | Director | Jul 03, 2012 | Sale | $35.04 | 5,000 | 175,200 | 929,711 | Jul 03, 2012, 02:23 PM |
CORNELIUS JAMES M | Director | Jul 02, 2012 | Sale | $35.93 | 5,000 | 179,650 | 934,711 | Jul 03, 2012, 02:23 PM |
CORNELIUS JAMES M | Director | Jun 27, 2012 | Sale | $35.07 | 5,000 | 175,350 | 939,016 | Jun 28, 2012, 04:28 PM |
CORNELIUS JAMES M | Director | Jun 26, 2012 | Sale | $34.54 | 5,000 | 172,700 | 944,016 | Jun 28, 2012, 04:28 PM |
CORNELIUS JAMES M | Director | Jun 21, 2012 | Sale | $34.84 | 5,000 | 174,200 | 954,016 | Jun 25, 2012, 04:08 PM |
CORNELIUS JAMES M | Director | Jun 22, 2012 | Sale | $34.99 | 5,000 | 174,950 | 949,016 | Jun 25, 2012, 04:08 PM |
CORNELIUS JAMES M | Director | Jun 15, 2012 | Sale | $34.45 | 5,000 | 172,250 | 959,016 | Jun 18, 2012, 04:18 PM |
CORNELIUS JAMES M | Director | Jun 14, 2012 | Sale | $34.55 | 5,000 | 172,750 | 964,016 | Jun 18, 2012, 04:18 PM |
CORNELIUS JAMES M | Director | Jun 06, 2012 | Sale | $33.98 | 5,000 | 169,900 | 969,016 | Jun 06, 2012, 05:57 PM |
CORNELIUS JAMES M | Director | Jun 05, 2012 | Sale | $33.69 | 5,000 | 168,450 | 974,016 | Jun 06, 2012, 05:57 PM |
CORNELIUS JAMES M | Director | May 29, 2012 | Sale | $33.29 | 5,000 | 166,450 | 984,016 | May 31, 2012, 04:05 PM |
CORNELIUS JAMES M | Director | May 30, 2012 | Sale | $33.49 | 5,000 | 167,450 | 979,016 | May 31, 2012, 04:05 PM |
CORNELIUS JAMES M | Director | May 23, 2012 | Sale | $32.48 | 5,000 | 162,400 | 989,016 | May 23, 2012, 05:27 PM |
CORNELIUS JAMES M | Director | May 22, 2012 | Sale | $32.88 | 5,000 | 164,400 | 994,016 | May 23, 2012, 05:27 PM |
CORNELIUS JAMES M | Director | May 18, 2012 | Sale | $32.77 | 5,000 | 163,850 | 999,016 | May 18, 2012, 05:40 PM |
CORNELIUS JAMES M | Director | May 17, 2012 | Sale | $33.00 | 5,000 | 165,000 | 1,004,016 | May 18, 2012, 05:40 PM |
CORNELIUS JAMES M | Director | May 08, 2012 | Sale | $33.09 | 5,000 | 165,450 | 1,009,016 | May 09, 2012, 04:20 PM |
CORNELIUS JAMES M | Director | May 07, 2012 | Sale | $33.51 | 5,000 | 167,550 | 1,014,016 | May 09, 2012, 04:20 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | May 04, 2012 | Option Exercise | $33.37 | 9,566 | 319,217 | 379,491 | May 07, 2012, 04:35 PM |
CORNELIUS JAMES M | Director | May 03, 2012 | Sale | $33.51 | 5,000 | 167,550 | 1,019,016 | May 03, 2012, 05:06 PM |
CORNELIUS JAMES M | Director | May 02, 2012 | Sale | $33.49 | 5,000 | 167,450 | 1,024,016 | May 03, 2012, 05:06 PM |
CORNELIUS JAMES M | Director | Apr 25, 2012 | Sale | $34.24 | 5,000 | 171,200 | 1,029,016 | Apr 25, 2012, 05:55 PM |
CORNELIUS JAMES M | Director | Apr 24, 2012 | Sale | $33.97 | 5,000 | 169,850 | 1,034,016 | Apr 25, 2012, 05:55 PM |
CORNELIUS JAMES M | Director | Apr 17, 2012 | Sale | $33.24 | 5,000 | 166,200 | 1,044,016 | Apr 18, 2012, 05:37 PM |
CORNELIUS JAMES M | Director | Apr 18, 2012 | Sale | $33.48 | 5,000 | 167,400 | 1,039,016 | Apr 18, 2012, 05:37 PM |
CORNELIUS JAMES M | Director | Apr 11, 2012 | Sale | $32.64 | 5,000 | 163,200 | 1,049,016 | Apr 11, 2012, 05:46 PM |
CORNELIUS JAMES M | Director | Apr 10, 2012 | Sale | $32.63 | 5,000 | 163,150 | 1,054,016 | Apr 11, 2012, 05:46 PM |
CORNELIUS JAMES M | Director | Apr 05, 2012 | Sale | $33.63 | 5,000 | 168,150 | 1,059,016 | Apr 06, 2012, 12:44 PM |
CORNELIUS JAMES M | Director | Apr 04, 2012 | Sale | $33.67 | 5,000 | 168,350 | 1,064,016 | Apr 06, 2012, 12:44 PM |
CORNELIUS JAMES M | Director | Mar 30, 2012 | Option Exercise | $33.75 | 740 | 24,975 | 1,069,016 | Apr 02, 2012, 04:19 PM |
GLIMCHER LAURIE H M.D. | Director | Mar 16, 2012 | Option Exercise | $28.38 | 3,500 | 99,313 | 3,500 | Mar 20, 2012, 04:45 PM |
GLIMCHER LAURIE H M.D. | Director | Mar 16, 2012 | Sale | $33.18 | 3,500 | 116,130 | 0 | Mar 20, 2012, 04:45 PM |
CAMPBELL LEWIS B | Director | Mar 16, 2012 | Option Exercise | $28.38 | 3,500 | 99,313 | 3,500 | Mar 20, 2012, 04:44 PM |
CAMPBELL LEWIS B | Director | Mar 16, 2012 | Sale | $33.16 | 3,500 | 116,060 | 0 | Mar 20, 2012, 04:44 PM |
Cuss Francis M | SVP Research | Mar 06, 2012 | Option Exercise | $32.33 | 6,931 | 224,079 | 117,594 | Mar 09, 2012, 04:47 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 06, 2012 | Option Exercise | $32.33 | 11,375 | 367,754 | 64,365 | Mar 09, 2012, 06:00 AM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 06, 2012 | Option Exercise | $32.33 | 11,152 | 360,544 | 151,611 | Mar 08, 2012, 09:56 PM |
von Autenried Paul | SVP & CIO | Mar 06, 2012 | Option Exercise | $32.33 | 4,118 | 133,135 | 34,213 | Mar 08, 2012, 09:54 PM |
CORNELIUS JAMES M | Director | Mar 06, 2012 | Option Exercise | $32.33 | 57,485 | 1,858,490 | 1,092,744 | Mar 08, 2012, 09:51 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 06, 2012 | Option Exercise | $32.33 | 39,784 | 1,286,217 | 335,437 | Mar 08, 2012, 09:27 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 06, 2012 | Option Exercise | $32.33 | 55,408 | 1,791,341 | 422,181 | Mar 08, 2012, 09:27 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Mar 06, 2012 | Option Exercise | $32.33 | 3,204 | 103,585 | 52,702 | Mar 08, 2012, 09:27 PM |
Caldarella Joseph C | SVP & Controller | Mar 06, 2012 | Option Exercise | $32.33 | 4,585 | 148,233 | 59,314 | Mar 08, 2012, 09:27 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 06, 2012 | Option Exercise | $32.33 | 4,626 | 149,559 | 66,795 | Mar 08, 2012, 09:27 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 06, 2012 | Option Exercise | $32.33 | 24,428 | 789,757 | 161,804 | Mar 08, 2012, 09:27 PM |
Cazala Beatrice J | EVP Commercial Operations | Mar 07, 2012 | Option Exercise | $32.48 | 2,102 | 68,273 | 192,219 | Mar 08, 2012, 09:27 PM |
Cazala Beatrice J | EVP Commercial Operations | Mar 06, 2012 | Option Exercise | $32.33 | 25,072 | 810,578 | 213,670 | Mar 08, 2012, 09:27 PM |
von Autenried Paul | SVP & CIO | Mar 03, 2012 | Option Exercise | $32.59 | 881 | 28,712 | 26,271 | Mar 05, 2012, 07:43 PM |
von Autenried Paul | SVP & CIO | Mar 02, 2012 | Option Exercise | $32.59 | 850 | 27,702 | 24,730 | Mar 05, 2012, 07:43 PM |
von Autenried Paul | SVP & CIO | Mar 01, 2012 | Option Exercise | $32.64 | 1,470 | 47,981 | 23,244 | Mar 05, 2012, 07:43 PM |
von Autenried Paul | SVP & CIO | Mar 04, 2012 | Option Exercise | $32.59 | 420 | 13,688 | 27,006 | Mar 05, 2012, 07:43 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 04, 2012 | Option Exercise | $32.59 | 3,455 | 112,598 | 252,794 | Mar 05, 2012, 07:43 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 03, 2012 | Option Exercise | $32.59 | 21,491 | 700,392 | 248,796 | Mar 05, 2012, 07:43 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 02, 2012 | Option Exercise | $32.59 | 7,383 | 240,612 | 223,922 | Mar 05, 2012, 07:43 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 01, 2012 | Option Exercise | $32.64 | 5,412 | 176,648 | 215,377 | Mar 05, 2012, 07:43 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 01, 2012 | Option Exercise | $32.64 | 3,415 | 111,466 | 98,199 | Mar 05, 2012, 07:43 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 04, 2012 | Option Exercise | $32.59 | 1,442 | 46,995 | 109,987 | Mar 05, 2012, 07:43 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 03, 2012 | Option Exercise | $32.59 | 1,736 | 56,576 | 107,449 | Mar 05, 2012, 07:43 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 02, 2012 | Option Exercise | $32.59 | 3,518 | 114,652 | 104,393 | Mar 05, 2012, 07:43 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 04, 2012 | Option Exercise | $32.59 | 680 | 22,161 | 47,667 | Mar 05, 2012, 07:43 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 03, 2012 | Option Exercise | $32.59 | 979 | 31,906 | 46,477 | Mar 05, 2012, 07:43 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 02, 2012 | Option Exercise | $32.59 | 1,831 | 59,672 | 44,765 | Mar 05, 2012, 07:43 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 01, 2012 | Option Exercise | $32.64 | 1,711 | 55,847 | 41,561 | Mar 05, 2012, 07:43 PM |
Cuss Francis M | SVP Research | Mar 04, 2012 | Option Exercise | $32.59 | 1,105 | 36,012 | 106,659 | Mar 05, 2012, 07:43 PM |
Cuss Francis M | SVP Research | Mar 03, 2012 | Option Exercise | $32.59 | 1,365 | 44,485 | 104,725 | Mar 05, 2012, 07:43 PM |
Cuss Francis M | SVP Research | Mar 02, 2012 | Option Exercise | $32.59 | 1,983 | 64,626 | 102,337 | Mar 05, 2012, 07:43 PM |
Cuss Francis M | SVP Research | Mar 01, 2012 | Option Exercise | $32.64 | 1,711 | 55,847 | 98,866 | Mar 05, 2012, 07:43 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 04, 2012 | Option Exercise | $32.59 | 786 | 25,616 | 120,964 | Mar 05, 2012, 07:43 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 03, 2012 | Option Exercise | $32.59 | 874 | 28,484 | 119,090 | Mar 05, 2012, 07:43 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 02, 2012 | Option Exercise | $32.59 | 1,363 | 44,420 | 117,004 | Mar 05, 2012, 07:43 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 01, 2012 | Option Exercise | $32.64 | 1,216 | 39,690 | 113,752 | Mar 05, 2012, 07:43 PM |
Cazala Beatrice J | EVP Commercial Operations | Mar 02, 2012 | Option Exercise | $32.59 | 3,259 | 106,211 | 161,783 | Mar 05, 2012, 07:43 PM |
Cazala Beatrice J | EVP Commercial Operations | Mar 01, 2012 | Option Exercise | $32.64 | 4,337 | 141,560 | 156,077 | Mar 05, 2012, 07:43 PM |
Caldarella Joseph C | SVP & Controller | Mar 02, 2012 | Option Exercise | $32.59 | 946 | 30,830 | 49,988 | Mar 05, 2012, 07:43 PM |
Caldarella Joseph C | SVP & Controller | Mar 01, 2012 | Option Exercise | $32.64 | 1,273 | 41,551 | 48,598 | Mar 05, 2012, 07:43 PM |
Caldarella Joseph C | SVP & Controller | Mar 04, 2012 | Option Exercise | $32.59 | 797 | 25,974 | 52,574 | Mar 05, 2012, 07:43 PM |
Caldarella Joseph C | SVP & Controller | Mar 03, 2012 | Option Exercise | $32.59 | 963 | 31,384 | 51,404 | Mar 05, 2012, 07:43 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Mar 04, 2012 | Option Exercise | $32.59 | 552 | 17,990 | 47,095 | Mar 05, 2012, 07:43 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Mar 03, 2012 | Option Exercise | $32.59 | 673 | 21,933 | 46,130 | Mar 05, 2012, 07:43 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Mar 02, 2012 | Option Exercise | $32.59 | 575 | 18,739 | 44,952 | Mar 05, 2012, 07:43 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Mar 01, 2012 | Option Exercise | $32.64 | 690 | 22,522 | 43,946 | Mar 05, 2012, 07:43 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 04, 2012 | Option Exercise | $32.59 | 746 | 24,312 | 60,096 | Mar 05, 2012, 07:43 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 03, 2012 | Option Exercise | $32.59 | 905 | 29,494 | 58,790 | Mar 05, 2012, 07:43 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 02, 2012 | Option Exercise | $32.59 | 2,716 | 88,514 | 57,208 | Mar 05, 2012, 07:43 PM |
Bancroft Charles A | EVP & Chief Financial Officer | Mar 01, 2012 | Option Exercise | $32.64 | 4,503 | 146,978 | 52,453 | Mar 05, 2012, 07:43 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 03, 2012 | Option Exercise | $32.59 | 5,221 | 170,152 | 312,042 | Mar 05, 2012, 07:43 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 02, 2012 | Option Exercise | $32.59 | 10,896 | 355,101 | 306,919 | Mar 05, 2012, 07:43 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 01, 2012 | Option Exercise | $32.64 | 18,499 | 603,807 | 296,226 | Mar 05, 2012, 07:43 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 04, 2012 | Option Exercise | $32.59 | 3,762 | 122,604 | 315,733 | Mar 05, 2012, 07:43 PM |
Caforio Giovanni | Pres., US Pharmaceuticals | Jan 03, 2012 | Option Exercise | $35.01 | 3,579 | 125,301 | 42,739 | Jan 04, 2012, 06:32 PM |
CORNELIUS JAMES M | Director | Dec 31, 2011 | Option Exercise | $35.24 | 709 | 24,985 | 994,133 | Jan 04, 2012, 05:40 PM |
Cazala Beatrice J | SVP Comm Ops & Pres GC Euro EM | Mar 01, 2011 | Option Exercise | $25.58 | 5,553 | 142,046 | 145,199 | Dec 29, 2011, 10:36 AM |
CORNELIUS JAMES M | Director | Oct 31, 2011 | Option Exercise | $17.51 | 440,188 | 7,707,692 | 1,433,612 | Nov 01, 2011, 04:39 PM |
CORNELIUS JAMES M | Director | Oct 31, 2011 | Sale | $31.87 | 440,188 | 14,029,804 | 993,424 | Nov 01, 2011, 04:39 PM |
LEVIN JEREMY M | SVP Strat Transactions | Oct 01, 2011 | Option Exercise | $31.38 | 4,704 | 147,612 | 43,689 | Oct 04, 2011, 08:29 PM |
CORNELIUS JAMES M | Director | Sep 30, 2011 | Option Exercise | $31.38 | 796 | 24,978 | 993,424 | Oct 04, 2011, 08:02 PM |
CORNELIUS JAMES M | Director | Sep 26, 2011 | Option Exercise | $17.51 | 500,000 | 8,755,000 | 992,628 | Sep 27, 2011, 04:35 PM |
Caldarella Joseph C | SVP & Controller | Aug 17, 2011 | Option Exercise | $28.46 | 13,082 | 372,357 | 59,049 | Aug 18, 2011, 04:29 PM |
Caldarella Joseph C | SVP & Controller | Aug 17, 2011 | Option Exercise | $25.45 | 13,781 | 350,726 | 59,867 | Aug 18, 2011, 04:29 PM |
Caldarella Joseph C | SVP & Controller | Aug 17, 2011 | Sale | $28.46 | 58 | 1,651 | 59,809 | Aug 18, 2011, 04:29 PM |
CORNELIUS JAMES M | Director | Aug 11, 2011 | Option Exercise | $17.51 | 200,000 | 3,502,000 | 492,628 | Aug 15, 2011, 05:16 PM |
CORNELIUS JAMES M | Director | Jun 30, 2011 | Option Exercise | $28.96 | 863 | 24,992 | 292,628 | Jul 05, 2011, 02:49 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Jun 14, 2011 | Option Exercise | $27.76 | 205,073 | 5,692,129 | 304,127 | Jun 15, 2011, 04:17 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Jun 14, 2011 | Option Exercise | $27.76 | 221,455 | 6,146,838 | 319,033 | Jun 15, 2011, 04:17 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Jun 14, 2011 | Sale | $27.76 | 106,382 | 2,952,803 | 287,745 | Jun 15, 2011, 04:17 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | May 16, 2011 | Option Exercise | $28.90 | 228,681 | 6,609,201 | 443,022 | May 18, 2011, 07:12 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | May 18, 2011 | Option Exercise | $28.70 | 150,299 | 4,313,747 | 325,223 | May 18, 2011, 07:12 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | May 18, 2011 | Option Exercise | $28.70 | 185,579 | 5,326,321 | 356,931 | May 18, 2011, 07:12 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | May 16, 2011 | Option Exercise | $28.90 | 259,600 | 7,502,803 | 470,838 | May 18, 2011, 07:12 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | May 18, 2011 | Sale | $28.70 | 730 | 20,952 | 356,201 | May 18, 2011, 07:12 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | May 16, 2011 | Sale | $28.90 | 70,805 | 2,046,265 | 470,483 | May 18, 2011, 07:12 PM |
HOOPER ANTHONY C | SVP ComOps Pres USJap Int | May 13, 2011 | Option Exercise | $28.80 | 327,636 | 9,435,687 | 482,937 | May 17, 2011, 05:51 PM |
HOOPER ANTHONY C | SVP ComOps Pres USJap Int | May 13, 2011 | Option Exercise | $28.80 | 381,750 | 10,994,132 | 544,178 | May 17, 2011, 05:51 PM |
HOOPER ANTHONY C | SVP ComOps Pres USJap Int | May 13, 2011 | Sale | $28.80 | 13,372 | 385,104 | 530,806 | May 17, 2011, 05:51 PM |
Celentano John E | SVP HR Public Affairs & Philan | May 12, 2011 | Option Exercise | $28.63 | 116,790 | 3,344,188 | 236,356 | May 12, 2011, 06:45 PM |
Celentano John E | SVP HR Public Affairs & Philan | May 12, 2011 | Option Exercise | $28.63 | 136,955 | 3,921,597 | 250,440 | May 12, 2011, 06:45 PM |
Celentano John E | SVP HR Public Affairs & Philan | May 10, 2011 | Sale | $28.81 | 3,700 | 106,597 | 0 | May 12, 2011, 06:45 PM |
Celentano John E | SVP HR Public Affairs & Philan | May 12, 2011 | Sale | $28.53 | 22,800 | 650,468 | 213,556 | May 12, 2011, 06:45 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | May 09, 2011 | Option Exercise | $28.74 | 41,552 | 1,194,217 | 129,548 | May 11, 2011, 04:23 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | May 09, 2011 | Option Exercise | $28.74 | 52,474 | 1,508,118 | 141,958 | May 11, 2011, 04:23 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | May 09, 2011 | Sale | $28.74 | 2,828 | 81,278 | 139,130 | May 11, 2011, 04:23 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | May 09, 2011 | Sale | $28.77 | 20,880 | 600,718 | 38,567 | May 10, 2011, 10:14 AM |
ANDREOTTI LAMBERTO | Chief Executive Officer | May 04, 2011 | Option Exercise | $28.71 | 8,016 | 230,139 | 272,112 | May 06, 2011, 11:18 AM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | May 01, 2011 | Option Exercise | $28.10 | 1,236 | 34,732 | 59,447 | May 02, 2011, 04:57 PM |
Cuss Francis M | SVP Research, R&D | May 01, 2011 | Option Exercise | $28.10 | 1,236 | 34,732 | 95,872 | May 02, 2011, 04:57 PM |
CORNELIUS JAMES M | Director | Mar 31, 2011 | Option Exercise | $26.43 | 945 | 24,976 | 740,154 | Apr 04, 2011, 03:15 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 02, 2011 | Option Exercise | $25.39 | 1,437 | 36,485 | 58,207 | Mar 16, 2011, 04:34 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 01, 2011 | Option Exercise | $25.58 | 11,934 | 305,272 | 62,333 | Mar 16, 2011, 04:34 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 02, 2011 | Option Exercise | $25.39 | 5,796 | 147,160 | 207,107 | Mar 16, 2011, 04:34 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 02, 2011 | Option Exercise | $25.39 | 3,524 | 89,474 | 88,220 | Mar 16, 2011, 04:34 PM |
HOOPER ANTHONY C | SVP ComOps Pres USJap Int | Mar 02, 2011 | Option Exercise | $25.39 | 4,287 | 108,847 | 158,335 | Mar 16, 2011, 04:34 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Mar 01, 2011 | Option Exercise | $25.58 | 12,238 | 313,048 | 88,889 | Mar 16, 2011, 04:34 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Mar 02, 2011 | Option Exercise | $25.39 | 2,754 | 69,924 | 86,362 | Mar 16, 2011, 04:34 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 02, 2011 | Option Exercise | $25.39 | 1,432 | 36,358 | 110,634 | Mar 16, 2011, 04:34 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 02, 2011 | Option Exercise | $25.39 | 8,553 | 217,161 | 261,932 | Mar 16, 2011, 04:34 PM |
Cazala Beatrice J | SVP Comm Ops & Pres GC Euro EM | Mar 02, 2011 | Option Exercise | $25.39 | 2,715 | 68,934 | 142,731 | Mar 16, 2011, 04:34 PM |
CORNELIUS JAMES M | Director | Feb 17, 2011 | Buy | $25.73 | 900 | 23,160 | 369,737 | Mar 16, 2011, 04:33 PM |
LEVIN JEREMY M | SVP Strat Transactions | Mar 01, 2011 | Option Exercise | $25.58 | 5,240 | 134,039 | 37,854 | Mar 16, 2011, 04:31 PM |
Bancroft Charles A | Chief Financial Officer | Mar 01, 2011 | Option Exercise | $25.58 | 6,049 | 154,733 | 40,417 | Mar 16, 2011, 04:31 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 01, 2011 | Option Exercise | $25.58 | 50,096 | 1,281,456 | 230,320 | Mar 16, 2011, 04:31 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 01, 2011 | Option Exercise | $25.58 | 31,474 | 805,105 | 103,310 | Mar 16, 2011, 04:31 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 01, 2011 | Option Exercise | $25.58 | 13,114 | 335,456 | 115,929 | Mar 16, 2011, 04:31 PM |
Caldarella Joseph C | SVP & Controller | Mar 01, 2011 | Option Exercise | $25.58 | 6,735 | 172,281 | 45,316 | Mar 16, 2011, 04:31 PM |
Cazala Beatrice J | SVP Comm Ops & Pres GC Euro EM | Mar 01, 2011 | Option Exercise | $25.58 | 12,343 | 315,734 | 145,219 | Mar 16, 2011, 04:31 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 01, 2011 | Option Exercise | $25.58 | 58,550 | 1,497,709 | 286,119 | Mar 16, 2011, 04:31 PM |
Cazala Beatrice J | SVP Comm Ops & Pres GC Euro EM | Mar 12, 2011 | Option Exercise | $26.41 | 1,244 | 32,854 | 148,257 | Mar 15, 2011, 12:11 PM |
Cuss Francis M | SVP Dscvry & Exp Clinl Resrch | Mar 04, 2011 | Option Exercise | $26.43 | 1,105 | 29,205 | 95,644 | Mar 08, 2011, 05:32 PM |
Cuss Francis M | SVP Dscvry & Exp Clinl Resrch | Mar 06, 2011 | Option Exercise | $26.43 | 974 | 25,743 | 97,108 | Mar 08, 2011, 05:32 PM |
Caldarella Joseph C | SVP & Controller | Mar 06, 2011 | Option Exercise | $26.43 | 572 | 15,118 | 46,086 | Mar 08, 2011, 05:32 PM |
Caldarella Joseph C | SVP & Controller | Mar 04, 2011 | Option Exercise | $26.43 | 796 | 21,038 | 45,246 | Mar 08, 2011, 05:32 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Mar 07, 2011 | Option Exercise | $26.31 | 1,639 | 43,122 | 89,484 | Mar 08, 2011, 05:32 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Mar 06, 2011 | Option Exercise | $26.43 | 2,269 | 59,970 | 91,123 | Mar 08, 2011, 05:32 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Mar 04, 2011 | Option Exercise | $26.43 | 1,845 | 48,763 | 88,497 | Mar 08, 2011, 05:32 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 07, 2011 | Option Exercise | $26.31 | 3,554 | 93,506 | 211,238 | Mar 08, 2011, 05:32 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 06, 2011 | Option Exercise | $26.43 | 3,187 | 84,232 | 214,792 | Mar 08, 2011, 05:32 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Mar 04, 2011 | Option Exercise | $26.43 | 3,455 | 91,316 | 211,104 | Mar 08, 2011, 05:32 PM |
HOOPER ANTHONY C | SVP ComOps Pres USJap Int | Mar 07, 2011 | Option Exercise | $26.31 | 2,921 | 76,852 | 162,428 | Mar 08, 2011, 05:32 PM |
HOOPER ANTHONY C | SVP ComOps Pres USJap Int | Mar 06, 2011 | Option Exercise | $26.43 | 4,041 | 106,804 | 165,349 | Mar 08, 2011, 05:32 PM |
HOOPER ANTHONY C | SVP ComOps Pres USJap Int | Mar 04, 2011 | Option Exercise | $26.43 | 2,021 | 53,415 | 160,673 | Mar 08, 2011, 05:32 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 07, 2011 | Option Exercise | $26.31 | 1,331 | 35,019 | 113,485 | Mar 08, 2011, 05:32 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 06, 2011 | Option Exercise | $26.43 | 1,683 | 44,482 | 114,816 | Mar 08, 2011, 05:32 PM |
Celentano John E | SVP HR Public Affairs & Philan | Mar 04, 2011 | Option Exercise | $26.43 | 1,052 | 27,804 | 112,242 | Mar 08, 2011, 05:32 PM |
Cazala Beatrice J | SVP Comm Ops & Pres GC Euro EM | Mar 07, 2011 | Option Exercise | $26.31 | 1,867 | 49,121 | 146,819 | Mar 08, 2011, 05:32 PM |
Cazala Beatrice J | SVP Comm Ops & Pres GC Euro EM | Mar 06, 2011 | Option Exercise | $26.43 | 1,667 | 44,059 | 144,659 | Mar 08, 2011, 05:32 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 07, 2011 | Option Exercise | $26.31 | 4,644 | 122,184 | 264,246 | Mar 08, 2011, 05:32 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 06, 2011 | Option Exercise | $26.43 | 3,332 | 88,065 | 268,890 | Mar 08, 2011, 05:32 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Mar 04, 2011 | Option Exercise | $26.43 | 3,762 | 99,430 | 265,622 | Mar 08, 2011, 05:32 PM |
LEVIN JEREMY M | SVP Strat Transactions | Mar 04, 2011 | Option Exercise | $26.43 | 566 | 14,959 | 38,393 | Mar 08, 2011, 05:22 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 06, 2011 | Option Exercise | $26.43 | 1,572 | 41,548 | 92,188 | Mar 08, 2011, 05:22 PM |
LEUNG SANDRA | General Counsel & Secretary | Mar 04, 2011 | Option Exercise | $26.43 | 1,840 | 48,631 | 90,360 | Mar 08, 2011, 05:22 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 04, 2011 | Option Exercise | $26.43 | 680 | 17,972 | 59,397 | Mar 08, 2011, 05:22 PM |
DANIELS BRIAN | SVP Global Dev & Med Affairs | Mar 06, 2011 | Option Exercise | $26.43 | 1,081 | 28,571 | 60,683 | Mar 08, 2011, 05:22 PM |
Bancroft Charles A | Chief Financial Officer | Mar 06, 2011 | Option Exercise | $26.43 | 514 | 13,585 | 44,569 | Mar 08, 2011, 05:22 PM |
Bancroft Charles A | Chief Financial Officer | Mar 04, 2011 | Option Exercise | $26.43 | 746 | 19,717 | 43,671 | Mar 08, 2011, 05:22 PM |
LEVIN JEREMY M | SVP Strat Transactions | Mar 03, 2011 | Option Exercise | $26.14 | 818 | 21,383 | 37,562 | Mar 04, 2011, 09:20 PM |
LEVIN JEREMY M | SVP Strat Transactions | Mar 02, 2011 | Option Exercise | $25.39 | 968 | 24,578 | 36,361 | Mar 04, 2011, 09:20 PM |
Bancroft Charles A | Chief Financial Officer | Mar 03, 2011 | Option Exercise | $26.14 | 905 | 23,657 | 42,365 | Mar 04, 2011, 09:12 PM |
Bancroft Charles A | Chief Financial Officer | Mar 02, 2011 | Option Exercise | $25.39 | 2,132 | 54,131 | 40,783 | Mar 04, 2011, 09:12 PM |
Cuss Francis M | SVP Dscvry & Exp Clinl Resrch | Mar 03, 2011 | Option Exercise | $26.14 | 1,365 | 35,681 | 93,711 | Mar 04, 2011, 08:58 PM |
Cuss Francis M | SVP Dscvry & Exp Clinl Resrch | Mar 02, 2011 | Option Exercise | $25.39 | 1,557 | 39,532 | 91,323 | Mar 04, 2011, 08:58 PM |
Caldarella Joseph C | VP & Financial Controller | Mar 03, 2011 | Option Exercise | $26.14 | 963 | 25,173 | 44,076 | Mar 04, 2011, 08:58 PM |
Caldarella Joseph C | VP & Financial Controller | Mar 02, 2011 | Option Exercise | $25.39 | 742 | 18,839 | 42,660 | Mar 04, 2011, 08:58 PM |
CORNELIUS JAMES M | Director | Dec 31, 2010 | Option Exercise | $26.48 | 1,770 | 46,870 | 368,837 | Jan 04, 2011, 12:00 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Dec 17, 2010 | Sale | $26.45 | 10,000 | 264,500 | 60,652 | Dec 20, 2010, 04:23 PM |
Carlo de Notaristefani | Pres Tech Ops & Supp Fnctns | Dec 06, 2010 | Option Exercise | $25.89 | 2,781 | 72,000 | 70,652 | Dec 08, 2010, 09:34 AM |
Celentano John E | SVP HR Public Affairs & Philan | Dec 06, 2010 | Option Exercise | $25.89 | 2,635 | 68,220 | 78,586 | Dec 08, 2010, 09:34 AM |
Celentano John E | SVP HR Public Affairs & Philan | Sep 10, 2010 | Sale | $26.99 | 25,500 | 688,242 | 261,421 | Oct 18, 2010, 03:18 PM |
LEVIN JEREMY M | SVP Strat Transactions | Oct 01, 2010 | Option Exercise | $27.28 | 4,148 | 113,157 | 26,357 | Oct 05, 2010, 04:59 PM |
CORNELIUS JAMES M | Director | Sep 30, 2010 | Option Exercise | $27.11 | 1,729 | 46,873 | 394,036 | Oct 04, 2010, 02:07 PM |
HOOPER ANTHONY C | SVPComOps PresUSJapInterc | Sep 20, 2010 | Option Exercise | $27.81 | 3,863 | 107,430 | 108,519 | Sep 22, 2010, 02:38 PM |
SIGAL ELLIOT | EVP, CSO & President R&D | Sep 20, 2010 | Option Exercise | $27.81 | 7,726 | 214,860 | 134,496 | Sep 22, 2010, 02:38 PM |
ANDREOTTI LAMBERTO | Chief Executive Officer | Sep 20, 2010 | Option Exercise | $27.81 | 19,726 | 548,580 | 196,089 | Sep 22, 2010, 02:38 PM |
Celentano John E | SVP HR Public Affairs & Philan | Sep 10, 2010 | Sale | $26.99 | 180,200 | 4,863,580 | 222,996 | Sep 15, 2010, 08:12 PM |
Celentano John E | SVP HR Public Affairs & Philan | Sep 10, 2010 | Option Exercise | $23.52 | 221,580 | 5,211,732 | 286,921 | Sep 14, 2010, 05:55 PM |
Celentano John E | SVP HR Public Affairs & Philan | Sep 10, 2010 | Sale | $27.04 | 205,700 | 5,561,788 | 261,421 | Sep 14, 2010, 05:55 PM |
Caldarella Joseph C | VP & Financial Controller | Sep 10, 2010 | Option Exercise | $23.14 | 24,138 | 558,553 | 55,806 | Sep 14, 2010, 05:54 PM |
Caldarella Joseph C | VP & Financial Controller | Sep 10, 2010 | Sale | $27.04 | 24,138 | 652,612 | 31,668 | Sep 14, 2010, 05:54 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Gallman Cari | EVP, Corporate Affairs | 08/01/2024 | 18,497 |
Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | 04/01/2024 | 63,376 |
Lenkowsky Adam | EVP, Chief Commercial Officer | 03/10/2024 | 232,534 |
LEUNG SANDRA | EVP, General Counsel | 03/10/2024 | 896,141 |
Plenge Robert M | EVP, Chief Research Officer | 03/10/2024 | 105,697 |
Poole Ahn Amanda | EVP, Chief Human Resources | 03/10/2024 | 73,961 |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 03/10/2024 | 734,180 |
Holzer Phil M | SVP and Controller | 03/10/2024 | 74,714 |
Hoch Lynelle | President, Cell Therapy Org. | 03/10/2024 | 70,357 |
Gallman Cari | EVP, Corporate Affairs | 03/10/2024 | 37,438 |
BOERNER CHRISTOPHER S. | Chief Executive Officer | 03/10/2024 | 1,043,903 |
Elkins David V | EVP, Chief Financial Officer | 03/10/2024 | 996,298 |
Caforio Giovanni | Executive Chair of the Board | 03/10/2024 | 3,648,199 |
Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | 02/01/2024 | 36,697 |
BOERNER CHRISTOPHER S. | Chief Executive Officer | 12/05/2023 | 99,560 |
Plenge Robert M | EVP, Chief Research Officer | 12/02/2023 | 13,727 |
Elkins David V | EVP, Chief Financial Officer | 12/02/2023 | 186,873 |
BOERNER CHRISTOPHER S. | Chief Executive Officer | 12/02/2023 | 67,635 |
BOERNER CHRISTOPHER S. | Chief Executive Officer | 11/28/2023 | 150,049 |
LEUNG SANDRA | EVP, General Counsel | 11/21/2023 | 479,163 |
LEUNG SANDRA | EVP, General Counsel | 11/21/2023 | 479,163 |
Samuels Theodore R. II | Director | 11/20/2023 | 423,385 |
Powell Ann | EVP, Chief Human Resources | 08/24/2023 | 1,101,643 |
Plenge Robert M | EVP, Chief Research Officer | 08/03/2023 | 44,754 |
Weese Michelle | EVP, Corporate Affairs | 07/01/2023 | 43,614 |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 07/01/2023 | 306,129 |
Lenkowsky Adam | EVP, Chief Commercial Officer | 06/03/2023 | 36,179 |
VESSEY RUPERT | EVP & President, Research | 05/03/2023 | 3,378,818 |
Greenlees Sharon | SVP & Controller | 05/02/2023 | 23,563 |
Mily Elizabeth | EVP, Strategy & BD | 04/01/2023 | 221,653 |
Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | 04/01/2023 | 117,273 |
Mily Elizabeth | EVP, Strategy & BD | 03/10/2023 | 922,568 |
VESSEY RUPERT | EVP & President, Research | 03/10/2023 | 2,529,704 |
LEUNG SANDRA | EVP, General Counsel | 03/10/2023 | 2,240,974 |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 03/10/2023 | 1,471,575 |
Powell Ann | EVP, Chief Human Resources | 03/10/2023 | 1,104,585 |
Weese Michelle | EVP, Corporate Affairs | 03/10/2023 | 39,032 |
Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | 03/10/2023 | 81,678 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 03/10/2023 | 2,274,880 |
Elkins David V | EVP, Chief Financial Officer | 03/10/2023 | 2,715,860 |
Caforio Giovanni | Board Chair and CEO | 03/10/2023 | 9,067,257 |
Shanahan Karin | EVP, Glob. Prod. Dev. & Supply | 03/10/2023 | 60,059 |
Caforio Giovanni | Board Chair and CEO | 02/06/2023 | 17,916,000 |
Powell Ann | EVP, Chief Human Resources | 02/06/2023 | 835,258 |
Meyers Gregory Scott | EVP, Chief Digital & Tech Off. | 02/01/2023 | 52,069 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 12/02/2022 | 109,444 |
Elkins David V | EVP, Chief Financial Officer | 12/02/2022 | 364,923 |
VESSEY RUPERT | EVP, Research & Early Dev. | 12/02/2022 | 364,923 |
Powell Ann | EVP, Chief Human Resources | 11/09/2022 | 1,307,312 |
VESSEY RUPERT | EVP, Research & Early Dev. | 11/07/2022 | 3,067,529 |
VESSEY RUPERT | EVP, Research & Early Dev. | 11/07/2022 | 3,621,381 |
Caforio Giovanni | Board Chair and CEO | 09/20/2022 | 1,742,750 |
Caforio Giovanni | Board Chair and CEO | 09/15/2022 | 3,592,000 |
Elkins David V | EVP, Chief Financial Officer | 09/13/2022 | 5,977,702 |
Elkins David V | EVP, Chief Financial Officer | 09/13/2022 | 9,551,167 |
Powell Ann | EVP, Chief Human Resources | 09/14/2022 | 1,768,750 |
Caforio Giovanni | Board Chair and CEO | 06/13/2022 | 2,221,200 |
LEUNG SANDRA | EVP, General Counsel | 06/06/2022 | 4,867,850 |
Mily Elizabeth | EVP, Strategy & BD | 04/01/2022 | 246,042 |
Caforio Giovanni | Board Chair and CEO | 03/21/2022 | 1,788,000 |
VESSEY RUPERT | EVP, Research & Early Dev. | 03/16/2022 | 2,696,612 |
VESSEY RUPERT | EVP, Research & Early Dev. | 03/16/2022 | 5,162,973 |
Santiago Karen Murphy | SVP & Controller | 03/14/2022 | 455,096 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 03/14/2022 | 2,043,526 |
Caforio Giovanni | Board Chair and CEO | 03/10/2022 | 10,871,254 |
LEUNG SANDRA | EVP, General Counsel | 03/10/2022 | 3,072,126 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 03/10/2022 | 2,363,569 |
Elkins David V | EVP, Chief Financial Officer | 03/10/2022 | 630,969 |
Powell Ann | EVP, Chief Human Resources | 03/10/2022 | 1,393,647 |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 03/10/2022 | 356,126 |
Santiago Karen Murphy | SVP & Controller | 03/10/2022 | 425,778 |
VESSEY RUPERT | EVP, Research & Early Dev. | 03/10/2022 | 598,743 |
Mily Elizabeth | EVP, Strategy & BD | 03/10/2022 | 128,287 |
VESSEY RUPERT | EVP, Research & Early Dev. | 03/01/2022 | 707,095 |
Elkins David V | EVP, Chief Financial Officer | 03/01/2022 | 712,448 |
Caforio Giovanni | Board Chair and CEO | 02/24/2022 | 2,010,000 |
VESSEY RUPERT | EVP, Research & Early Dev. | 02/04/2022 | 85,267 |
VESSEY RUPERT | EVP, Research & Early Dev. | 12/16/2021 | 1,196,252 |
VESSEY RUPERT | EVP, Research & Early Dev. | 12/02/2021 | 249,234 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 12/02/2021 | 74,803 |
Elkins David V | EVP, Chief Financial Officer | 12/02/2021 | 249,234 |
von Autenried Paul | EVP, Chief Information Officer | 11/22/2021 | 1,049,813 |
von Autenried Paul | EVP, Chief Information Officer | 11/24/2021 | 987,733 |
von Autenried Paul | EVP, Chief Information Officer | 11/23/2021 | 886,072 |
Caforio Giovanni | Board Chair and CEO | 09/20/2021 | 1,516,000 |
Elkins David V | EVP, Chief Financial Officer | 08/12/2021 | 3,394,300 |
Elkins David V | EVP, Chief Financial Officer | 08/12/2021 | 6,674,497 |
Caforio Giovanni | Chairman and CEO | 08/02/2021 | 1,371,600 |
Powell Ann | EVP, Chief Human Resources | 08/03/2021 | 1,596,310 |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | 07/30/2021 | 167,441 |
Elkins David V | EVP, Chief Financial Officer | 08/01/2021 | 1,610,962 |
LEUNG SANDRA | EVP, General Counsel | 07/30/2021 | 1,999,696 |
VESSEY RUPERT | EVP, Research & Early Dev. | 07/30/2021 | 8,830,108 |
VESSEY RUPERT | EVP, Research & Early Dev. | 07/30/2021 | 10,782,154 |
von Autenried Paul | EVP, Chief Information Officer | 07/30/2021 | 1,701,375 |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 07/01/2021 | 318,556 |
Santiago Karen Murphy | SVP & Controller | 07/01/2021 | 36,408 |
Eid Joseph | SVP,Head Glob. Medical Affairs | 06/03/2021 | 47,822 |
Mily Elizabeth | EVP, Strategy & BD | 04/01/2021 | 185,769 |
Caforio Giovanni | Chairman and CEO | 03/22/2021 | 1,555,000 |
Caforio Giovanni | Chairman and CEO | 03/10/2021 | 6,838,357 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 03/10/2021 | 783,011 |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | 03/10/2021 | 116,376 |
Eid Joseph | SVP,Head Glob. Medical Affairs | 03/10/2021 | 133,559 |
Elkins David V | EVP, Chief Financial Officer | 03/10/2021 | 263,766 |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 03/10/2021 | 120,520 |
LEUNG SANDRA | EVP, General Counsel | 03/10/2021 | 1,901,016 |
Powell Ann | EVP, Chief Human Resources | 03/10/2021 | 873,066 |
Santiago Karen Murphy | SVP & Controller | 03/10/2021 | 162,196 |
Schmukler Louis S | EVP,Pres.,Glob.Prod. & Supply | 03/10/2021 | 888,908 |
VESSEY RUPERT | EVP, Research & Early Dev. | 03/10/2021 | 213,560 |
von Autenried Paul | EVP, Chief Information Officer | 03/10/2021 | 610,336 |
Elkins David V | EVP, Chief Financial Officer | 03/01/2021 | 528,354 |
VESSEY RUPERT | EVP, Research & Early Dev. | 03/01/2021 | 551,219 |
VESSEY RUPERT | EVP, Research & Early Dev. | 02/04/2021 | 73,010 |
VESSEY RUPERT | EVP, Research & Early Dev. | 12/31/2020 | 822,332 |
Elkins David V | EVP, Chief Financial Officer | 12/31/2020 | 740,080 |
AHMED NADIM | EVP and President, Hematology | 12/31/2020 | 475,150 |
VESSEY RUPERT | EVP, Research & Early Dev. | 12/02/2020 | 280,183 |
AHMED NADIM | EVP and President, Hematology | 12/02/2020 | 210,168 |
Elkins David V | EVP, Chief Financial Officer | 12/02/2020 | 316,310 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 12/02/2020 | 80,772 |
Eid Joseph | SVP,Head Glob. Medical Affairs | 12/01/2020 | 60,413 |
von Autenried Paul | EVP, Chief Information Officer | 11/25/2020 | 191 |
VESSEY RUPERT | EVP, Research & Early Dev. | 11/23/2020 | 823,244 |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | 11/24/2020 | 57,051 |
von Autenried Paul | EVP, Chief Information Officer | 11/24/2020 | 1,255,000 |
VESSEY RUPERT | EVP, Research & Early Dev. | 11/19/2020 | 2,572,887 |
VESSEY RUPERT | EVP, Research & Early Dev. | 11/19/2020 | 3,530,270 |
AHMED NADIM | EVP and President, Hematology | 10/30/2020 | 133,909 |
VESSEY RUPERT | EVP, Research & Early Dev. | 10/30/2020 | 167,109 |
Caforio Giovanni | Chairman and CEO | 08/31/2020 | 2,497,968 |
Santiago Karen Murphy | SVP & Controller | 09/01/2020 | 13,413 |
Eid Joseph | SVP,Head Glob. Medical Affairs | 08/17/2020 | 340,928 |
LEUNG SANDRA | EVP, General Counsel | 08/13/2020 | 8,943,401 |
Elkins David V | EVP, Chief Financial Officer | 08/01/2020 | 1,520,233 |
Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | 07/01/2020 | 265,236 |
Santiago Karen Murphy | SVP & Controller | 07/01/2020 | 21,811 |
Paliwal Dinesh C | Director | 06/15/2020 | 499,983 |
BONNEY MICHAEL W | Director | 12/04/2019 | 5,183 |
Eid Joseph | SVP,Head Glob. Medical Affairs | 06/03/2020 | 44,435 |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | 05/22/2020 | 195,232 |
Schmukler Louis S | EVP,Pres.,Glob.Prod. & Supply | 05/19/2020 | 1,567,000 |
VESSEY RUPERT | EVP, Research & Early Dev. | 05/01/2020 | 317,811 |
AHMED NADIM | EVP and President, Hematology | 05/01/2020 | 86,353 |
von Autenried Paul | EVP, Chief Information Officer | 03/10/2020 | 622,052 |
Schmukler Louis S | EVP,Pres.,Glob.Prod. & Supply | 03/10/2020 | 784,372 |
Santiago Karen Murphy | Controller | 03/10/2020 | 116,845 |
Powell Ann | EVP, Chief Human Resources | 03/10/2020 | 837,784 |
LEUNG SANDRA | EVP, General Counsel | 03/10/2020 | 1,640,114 |
Elicker John E | EVP, Investor Relations | 03/10/2020 | 455,330 |
Eid Joseph | SVP,Head Glob. Medical Affairs | 03/10/2020 | 36,786 |
Eid Joseph | SVP,Head Glob. Medical Affairs | 12/01/2019 | 55,118 |
Dubow Adam | SVP,ChiefCompliance&EthicsOff. | 03/10/2020 | 116,150 |
Caforio Giovanni | Chairman and CEO | 03/10/2020 | 6,774,508 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 03/10/2020 | 701,756 |
Bancroft Charles A | EVP, Head of Integration | 03/10/2020 | 1,930,286 |
Elicker John E | EVP, Investor Relations | 03/04/2020 | 964,263 |
VESSEY RUPERT | Pres., Research & Early Dev. | 03/02/2020 | 4,831,452 |
VESSEY RUPERT | Pres., Research & Early Dev. | 03/02/2020 | 5,108,222 |
VESSEY RUPERT | Pres., Research & Early Dev. | 03/01/2020 | 526,992 |
Elkins David V | EVP, Chief Financial Officer | 03/01/2020 | 618,358 |
AHMED NADIM | President, Hematology | 03/01/2020 | 500,415 |
VESSEY RUPERT | Pres., Research & Early Dev. | 02/04/2020 | 74,769 |
AHMED NADIM | President, Hematology | 02/04/2020 | 68,855 |
VESSEY RUPERT | Pres., Research & Early Dev. | 12/31/2019 | 507,743 |
VESSEY RUPERT | Pres., Research & Early Dev. | 12/31/2019 | 507,743 |
Elkins David V | EVP, Chief Financial Officer | 12/31/2019 | 391,174 |
Dubow Adam | Chief Compliance & Ethics Offi | 12/05/2019 | 102,329 |
Eid Joseph | SVPHead Global Medical Affairs | 12/01/2019 | 55,118 |
Schmukler Louis S | Pres., Global Mfg. & Supply | 11/05/2019 | 1,414,000 |
Elicker John E | SVP, Public Affairs & IR | 11/05/2019 | 849,900 |
Biondi Paul | SVP, Head of Strategy & BD | 10/02/2019 | 9,990 |
Santiago Karen Murphy | Controller | 09/01/2019 | 10,575 |
BERTOLINI ROBERT J | Director | 07/31/2019 | 491,920 |
Santiago Karen Murphy | Controller | 05/16/2019 | 145,771 |
Samuels Theodore R. II | Director | 05/16/2019 | 236,440 |
Caforio Giovanni | Chairman and CEO | 05/05/2019 | 134,872 |
Biondi Paul | SVP, Head of Strategy & BD | 10/02/2018 | 18,338 |
Lynch Thomas J. Jr. | EVP & Chief Scientific Officer | 04/03/2019 | 289,296 |
Elicker John E | SVP, Public Affairs & IR | 03/10/2019 | 233,311 |
Dubow Adam | Chief Compliance & Ethics Offi | 03/10/2019 | 60,743 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 03/10/2019 | 408,448 |
Caforio Giovanni | Chairman and CEO | 03/10/2019 | 4,415,018 |
Biondi Paul | SVP, Head of Strategy & BD | 03/10/2019 | 163,831 |
Bancroft Charles A | EVP & Chief Financial Officer | 03/10/2019 | 1,254,070 |
von Autenried Paul | SVP, Enterp. Services & CIO | 03/10/2019 | 460,249 |
Schmukler Louis S | Pres., Global Mfg. & Supply | 03/10/2019 | 535,278 |
Santiago Karen Murphy | Controller | 03/10/2019 | 61,462 |
Lynch Thomas J. Jr. | EVP & Chief Scientific Officer | 03/10/2019 | 122,462 |
LEUNG SANDRA | EVP, General Counsel | 03/10/2019 | 1,038,335 |
JUDGE ANN POWELL | SVP, Global Human Resources | 03/10/2019 | 666,169 |
LEUNG SANDRA | EVP, General Counsel | 02/28/2019 | 5,697,029 |
Bancroft Charles A | EVP & Chief Financial Officer | 02/28/2019 | 1,548,189 |
Bancroft Charles A | EVP & Chief Financial Officer | 02/28/2019 | 925,999 |
LEUNG SANDRA | EVP, General Counsel | 02/28/2019 | 2,974,826 |
Paliwal Dinesh C | Director | 04/30/2018 | 499,896 |
BOERNER CHRISTOPHER S. | EVP, Chief Commercial Officer | 02/02/2019 | 79,375 |
Bancroft Charles A | EVP & Chief Financial Officer | 12/02/2018 | 145,197 |
Bancroft Charles A | EVP & Chief Financial Officer | 12/02/2018 | 145,197 |
Biondi Paul | SVP, Head of Strategy & BD | 10/02/2018 | 18,338 |
Santiago Karen Murphy | Controller | 09/01/2018 | 13,321 |
Dubow Adam | Chief Compliance & Ethics Offi | 09/03/2018 | 16,530 |
Gordon Murdo | EVP, Chief Commercial Officer | 08/01/2018 | 44,357 |
Biondi Paul | SVP, Head of Strategy & BD | 07/01/2018 | 39,845 |
Caforio Giovanni | Chairman and CEO | 05/05/2018 | 161,484 |
Paliwal Dinesh C | Director | 04/30/2018 | 249,948 |
Lynch Thomas J. Jr. | EVP & Chief Scientific Officer | 04/03/2018 | 444,914 |
Schmukler Louis S | Pres., Global Mfg. & Supply | 03/10/2018 | 997,745 |
Elicker John E | SVP, Public Affairs & IR | 03/10/2018 | 530,523 |
JUDGE ANN POWELL | SVP, Global Human Resources | 03/10/2018 | 1,228,197 |
Caforio Giovanni | Chairman and CEO | 03/10/2018 | 7,531,988 |
Santiago Karen Murphy | Controller | 03/10/2018 | 106,906 |
Gordon Murdo | EVP, Chief Commercial Officer | 03/10/2018 | 1,363,969 |
LEUNG SANDRA | EVP, General Counsel | 03/10/2018 | 2,352,885 |
von Autenried Paul | SVP, Enterp. Services & CIO | 03/10/2018 | 1,015,676 |
Bancroft Charles A | EVP & Chief Financial Officer | 03/10/2018 | 2,731,131 |
Bancroft Charles A | EVP & Chief Financial Officer | 02/23/2018 | 1,387,144 |
Bancroft Charles A | EVP & Chief Financial Officer | 02/23/2018 | 829,364 |
Samuels Theodore R. II | Director | 12/15/2017 | 249,187 |
Lynch Thomas J. Jr. | EVP & Chief Scientific Officer | 12/12/2017 | 335,172 |
Bancroft Charles A | EVP & Chief Financial Officer | 12/02/2017 | 180,039 |
LEUNG SANDRA | EVP, General Counsel | 12/04/2017 | 3,466,725 |
LEUNG SANDRA | EVP, General Counsel | 12/04/2017 | 9,922,601 |
Elicker John E | SVP, Public Affairs & IR | 11/01/2017 | 13,862 |
Caldarella Joseph C | SVP & Controller | 09/06/2017 | 560,400 |
Nielsen Anne | Chief Compliance & Ethics Off | 09/03/2017 | 50,061 |
Samuels Theodore R. II | Director | 08/02/2017 | 335,622 |
Gordon Murdo | EVP, Chief Commercial Officer | 08/01/2017 | 43,926 |
Caforio Giovanni | Chairman and CEO | 05/05/2017 | 190,047 |
ANDREOTTI LAMBERTO | Director | 04/07/2017 | 904,791 |
ANDREOTTI LAMBERTO | Director | 04/06/2017 | 905,964 |
ANDREOTTI LAMBERTO | Director | 03/31/2017 | 24,960 |
JUDGE ANN POWELL | SVP, Global Human Resources | 04/01/2017 | 38,066 |
ANDREOTTI LAMBERTO | Director | 03/28/2017 | 955,369 |
ANDREOTTI LAMBERTO | Director | 03/27/2017 | 954,451 |
Caldarella Joseph C | SVP & Controller | 03/15/2017 | 463,779 |
Schmukler Louis S | Pres., Global Mfg. & Supply | 03/17/2017 | 282,470 |
Schmukler Louis S | Pres., Global Mfg. & Supply | 03/14/2017 | 851,220 |
LEUNG SANDRA | EVP, General Counsel | 03/10/2017 | 2,011,748 |
Cuss Francis M | EVP & CSO | 03/10/2017 | 2,009,241 |
Blin Emmanuel | SVP, Chief Strategy Officer | 03/10/2017 | 322,510 |
Caforio Giovanni | Chief Executive Officer | 03/10/2017 | 2,611,686 |
Bancroft Charles A | EVP & Chief Financial Officer | 03/10/2017 | 2,333,267 |
Gordon Murdo | EVP, Chief Commercial Officer | 03/10/2017 | 747,487 |
von Autenried Paul | SVP, Enterp. Services & CIO | 03/10/2017 | 904,018 |
ANDREOTTI LAMBERTO | Director | 03/10/2017 | 3,323,832 |
Nielsen Anne | Chief Compliance & Ethics Off | 03/10/2017 | 316,911 |
Schmukler Louis S | Pres., Global Mfg. & Supply | 03/10/2017 | 842,841 |
Elicker John E | SVP, Public Affairs & IR | 03/10/2017 | 441,891 |
JUDGE ANN POWELL | SVP, Global Human Resources | 03/10/2017 | 810,181 |
Caldarella Joseph C | SVP & Controller | 03/10/2017 | 442,882 |
LEUNG SANDRA | EVP, General Counsel | 03/03/2017 | 3,135,861 |
LEUNG SANDRA | EVP, General Counsel | 03/06/2017 | 5,268,563 |
Samuels Theodore R. II | Director | 02/27/2017 | 681,240 |
Bancroft Charles A | EVP & Chief Financial Officer | 02/28/2017 | 610,372 |
ANDREOTTI LAMBERTO | Director | 01/30/2017 | 2,701,000 |
Elicker John E | SVP, Public Affairs & IR | 01/03/2017 | 19,870 |
ANDREOTTI LAMBERTO | Director | 12/31/2016 | 24,954 |
Bancroft Charles A | EVP & Chief Financial Officer | 12/02/2016 | 161,333 |
Bancroft Charles A | EVP & Chief Financial Officer | 12/02/2016 | 161,333 |
ANDREOTTI LAMBERTO | Director | 11/01/2016 | 6,772,825 |
Bancroft Charles A | EVP & Chief Financial Officer | 11/01/2016 | 70,917 |
Elicker John E | SVP, Public Affairs & IR | 11/01/2016 | 11,328 |
ANDREOTTI LAMBERTO | Director | 10/11/2016 | 6,456,042 |
ANDREOTTI LAMBERTO | Director | 09/30/2016 | 24,965 |
ANDREOTTI LAMBERTO | Director | 09/08/2016 | 615,276 |
ANDREOTTI LAMBERTO | Director | 09/07/2016 | 613,116 |
Nielsen Anne | Chief Compliance & Ethics Off | 09/03/2016 | 48,359 |
ANDREOTTI LAMBERTO | Director | 08/25/2016 | 683,472 |
ANDREOTTI LAMBERTO | Director | 08/24/2016 | 689,359 |
Gordon Murdo | EVP, Chief Commercial Officer | 08/01/2016 | 59,733 |
ANDREOTTI LAMBERTO | Director | 07/08/2016 | 870,461 |
ANDREOTTI LAMBERTO | Director | 07/07/2016 | 856,776 |
Cuss Francis M | EVP & CSO | 07/01/2016 | 139,887 |
Gordon Murdo | EVP, Chief Commercial Officer | 07/01/2016 | 89,348 |
Blin Emmanuel | SVP, Chief Strategy Officer | 07/02/2016 | 16,158 |
ANDREOTTI LAMBERTO | Director | 06/30/2016 | 34,863 |
ANDREOTTI LAMBERTO | Director | 03/31/2016 | 53,084 |
ANDREOTTI LAMBERTO | Director | 06/29/2016 | 713,342 |
ANDREOTTI LAMBERTO | Director | 06/28/2016 | 960,396 |
Elicker John E | SVP, Public Affairs & IR | 06/14/2016 | 859,219 |
Bancroft Charles A | EVP & Chief Financial Officer | 05/20/2016 | 2,137,838 |
Caldarella Joseph C | SVP & Controller | 05/16/2016 | 255,004 |
LEUNG SANDRA | EVP, General Counsel | 05/06/2016 | 2,474,000 |
LEUNG SANDRA | EVP, General Counsel | 05/06/2016 | 5,106,372 |
Caforio Giovanni | Chief Executive Officer | 05/05/2016 | 318,510 |
ANDREOTTI LAMBERTO | Director | 05/04/2016 | 817,568 |
ANDREOTTI LAMBERTO | Director | 05/05/2016 | 818,844 |
Caforio Giovanni | Chief Executive Officer | 05/03/2016 | 1,250,602 |
Caforio Giovanni | Chief Executive Officer | 05/03/2016 | 2,466,885 |
Nielsen Anne | Chief Compliance & Ethics Off | 05/02/2016 | 2,045,172 |
von Autenried Paul | SVP, Enterp. Services & CIO | 05/02/2016 | 901,835 |
von Autenried Paul | SVP, Enterp. Services & CIO | 05/02/2016 | 2,679,819 |
ANDREOTTI LAMBERTO | Director | 05/02/2016 | 6,112,787 |
ANDREOTTI LAMBERTO | Director | 05/02/2016 | 16,870,792 |
Schmukler Louis S | Pres., Global Mfg. & Supply | 05/02/2016 | 1,598,652 |
ANDREOTTI LAMBERTO | Director | 04/05/2016 | 765,626 |
ANDREOTT |